Express (EXPRQ) 10-Q 7 Dec 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Oct. 28, 2023	Dec. 05, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 28, 2023
Document Transition Report	false
Entity File Number	001-34742
Entity Registrant Name	EXPRESS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-2828128
Entity Address, Address Line One	1 Express Drive
Entity Address, City or Town	Columbus
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43230
City Area Code	614
Local Phone Number	474-4001
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	EXPR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Outstanding (in shares)		3,746,258
Entity Central Index Key	0001483510
Current Fiscal Year End Date	--02-03
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023
Current Assets:
Cash and cash equivalents	$ 34,643	$ 65,612
Receivables, net	32,136	12,374
Income tax receivable	2,439	1,462
Inventories	480,867	365,649
Prepaid royalty	18,712	59,565
Prepaid rent	5,083	7,744
Other	24,999	21,998
Total current assets	598,879	534,404
Right of Use Asset, Net	534,209	505,350
Property and Equipment	1,017,462	1,019,577
Less: accumulated depreciation	(900,482)	(886,193)
Property and equipment, net	116,980	133,384
Non-Current Income Tax Receivable	45,079	52,278
Equity Method Investment	166,210	166,106
Other Assets	6,401	6,803
TOTAL ASSETS	1,467,758	1,398,325
Current Liabilities:
Short-term lease liability	189,296	189,006
Accounts payable	263,221	191,386
Deferred royalty income	3,832	19,852
Deferred revenue	39,395	35,543
Short-term debt	4,159	0
Accrued expenses	113,165	105,803
Total current liabilities	613,068	541,590
Long-Term Lease Liability	417,590	406,448
Total long-term debt, net	270,513	122,000
Other Long-Term Liabilities	18,632	20,718
Total Liabilities	1,319,803	1,090,756
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Preferred stock – $0.01 par value; 10,000 shares authorized; no shares issued or outstanding	0	0
Common stock – $0.01 par value; 25,000 shares authorized; 4,953 shares and 4,953 shares issued at October 28, 2023 and January 28, 2023, respectively, and 3,746 shares and 3,688 shares outstanding at October 28, 2023 and January 28, 2023, respectively	50	50
Additional paid-in capital	223,343	229,573
Retained earnings	185,120	355,736
Treasury stock – at average cost; 1,207 shares and 1,265 shares at October 28, 2023 and January 28, 2023, respectively	(260,558)	(277,790)
Total stockholders’ equity	147,955	307,569
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,467,758	$ 1,398,325

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Oct. 28, 2023	Jan. 28, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	25,000,000	25,000,000
Common stock, issued (in shares)	4,953,000	4,953,000
Common stock, outstanding (in shares)	3,746,000	3,688,000
Treasury stock (in shares)	1,207,000	1,265,000

Consolidated Statements of Inco

Consolidated Statements of Income and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Income Statement [Abstract]
Net Sales	$ 454,063	$ 434,145	$ 1,272,664	$ 1,349,849
Cost of Goods Sold, Buying and Occupancy Costs	344,546	313,528	998,985	944,031
GROSS PROFIT	109,517	120,617	273,679	405,818
Operating Expenses (Income):
Selling, general, and administrative expenses	143,645	150,090	429,084	434,461
Royalty income	(5,387)	0	(16,020)	0
Other operating expense (income), net	1	36	(957)	(443)
TOTAL OPERATING EXPENSES	138,259	150,126	412,107	434,018
OPERATING LOSS	(28,742)	(29,509)	(138,428)	(28,200)
Interest Expense, Net	6,170	4,668	12,987	11,962
Other Income, Net	0	(509)	0	(1,385)
LOSS BEFORE INCOME TAXES	(34,912)	(33,668)	(151,415)	(38,777)
Income Tax Expense	1,899	780	2,879	549
NET LOSS	(36,811)	(34,448)	(154,294)	(39,326)
COMPREHENSIVE LOSS	$ (36,811)	$ (34,448)	$ (154,294)	$ (39,326)
EARNINGS PER SHARE:
Basic (in USD per share)	$ (9.83)	$ (10.09)	$ (41.42)	$ (11.59)
Diluted (in USD per share)	$ (9.83)	$ (10.09)	$ (41.42)	$ (11.59)
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic (in shares)	3,746	3,414	3,725	3,394
Diluted (in shares)	3,746	3,414	3,725	3,394

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Balance, at start of period (in shares) at Jan. 29, 2022		3,354,000
Balance, at start of period at Jan. 29, 2022	$ 1,308	$ 47	$ 220,967	$ 77,093	$ 0	$ (296,799)
Balance, at start of period, treasury stock (in shares) at Jan. 29, 2022						1,328,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(11,914)			(11,914)
Exercise of stock options and vesting of restricted stock units (in shares)		76,000				(76,000)
Exercise of stock options and vesting of restricted stock units	0		(5,038)	(11,935)		$ 16,973
Share-based compensation	2,393		2,393
Repurchase of common stock (in shares)		(29,000)				29,000
Repurchase of common stock	(1,890)					$ (1,890)
Balance, at end of period (in shares) at Apr. 30, 2022		3,401,000
Balance, at end of period at Apr. 30, 2022	(10,103)	$ 47	218,322	53,244	0	$ (281,716)
Balance, at end of period, treasury stock (in shares) at Apr. 30, 2022						1,281,000
Balance, at start of period (in shares) at Jan. 29, 2022		3,354,000
Balance, at start of period at Jan. 29, 2022	1,308	$ 47	220,967	77,093	0	$ (296,799)
Balance, at start of period, treasury stock (in shares) at Jan. 29, 2022						1,328,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (39,326)
Repurchase of common stock (in shares)	0
Balance, at end of period (in shares) at Oct. 29, 2022		3,415,000
Balance, at end of period at Oct. 29, 2022	$ (32,401)	$ 47	222,787	22,872	0	$ (278,107)
Balance, at end of period, treasury stock (in shares) at Oct. 29, 2022						1,267,000
Balance, at start of period (in shares) at Apr. 30, 2022		3,401,000
Balance, at start of period at Apr. 30, 2022	(10,103)	$ 47	218,322	53,244	0	$ (281,716)
Balance, at start of period, treasury stock (in shares) at Apr. 30, 2022						1,281,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	7,036			7,036
Exercise of stock options and vesting of restricted stock units (in shares)		12,000				(12,000)
Exercise of stock options and vesting of restricted stock units	0		(636)	(2,035)		$ 2,671
Share-based compensation	2,620		2,620
Repurchase of common stock (in shares)		(1,000)				1,000
Repurchase of common stock	(66)					$ (66)
Balance, at end of period (in shares) at Jul. 30, 2022		3,412,000
Balance, at end of period at Jul. 30, 2022	(513)	$ 47	220,306	58,245	0	$ (279,111)
Balance, at end of period, treasury stock (in shares) at Jul. 30, 2022						1,270,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(34,448)			(34,448)
Exercise of stock options and vesting of restricted stock units (in shares)		5,000				(5,000)
Exercise of stock options and vesting of restricted stock units	0		(123)	(925)		$ 1,048
Share-based compensation	$ 2,604		2,604
Repurchase of common stock (in shares)	0	(2,000)				2,000
Repurchase of common stock	$ (44)					$ (44)
Balance, at end of period (in shares) at Oct. 29, 2022		3,415,000
Balance, at end of period at Oct. 29, 2022	$ (32,401)	$ 47	222,787	22,872	0	$ (278,107)
Balance, at end of period, treasury stock (in shares) at Oct. 29, 2022						1,267,000
Balance, at start of period (in shares) at Jan. 28, 2023	3,688,000	3,688,000
Balance, at start of period at Jan. 28, 2023	$ 307,569	$ 50	229,573	355,736	0	$ (277,790)
Balance, at start of period, treasury stock (in shares) at Jan. 28, 2023	1,265,000					1,265,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (73,427)			(73,427)
Exercise of stock options and vesting of restricted stock units (in shares)		62,000				(62,000)
Exercise of stock options and vesting of restricted stock units	0		(1,036)	(12,497)		$ 13,533
Share-based compensation	1,871		1,871
Repurchase of common stock (in shares)		(21,000)				21,000
Repurchase of common stock	(354)					$ (354)
Balance, at end of period (in shares) at Apr. 29, 2023		3,729,000
Balance, at end of period at Apr. 29, 2023	$ 235,659	$ 50	230,408	269,812	0	$ (264,611)
Balance, at end of period, treasury stock (in shares) at Apr. 29, 2023						1,224,000
Balance, at start of period (in shares) at Jan. 28, 2023	3,688,000	3,688,000
Balance, at start of period at Jan. 28, 2023	$ 307,569	$ 50	229,573	355,736	0	$ (277,790)
Balance, at start of period, treasury stock (in shares) at Jan. 28, 2023	1,265,000					1,265,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (154,294)
Repurchase of common stock (in shares)	0
Balance, at end of period (in shares) at Oct. 28, 2023	3,746,000	3,746,000
Balance, at end of period at Oct. 28, 2023	$ 147,955	$ 50	223,343	185,120	0	$ (260,558)
Balance, at end of period, treasury stock (in shares) at Oct. 28, 2023	1,207,000					1,207,000
Balance, at start of period (in shares) at Apr. 29, 2023		3,729,000
Balance, at start of period at Apr. 29, 2023	$ 235,659	$ 50	230,408	269,812	0	$ (264,611)
Balance, at start of period, treasury stock (in shares) at Apr. 29, 2023						1,224,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(44,056)			(44,056)
Exercise of stock options and vesting of restricted stock units (in shares)		16,000				(16,000)
Exercise of stock options and vesting of restricted stock units	0		(214)	(3,321)		$ 3,535
Share-based compensation	(5,681)		(5,681)
Repurchase of common stock	(6)					(6)
Balance, at end of period (in shares) at Jul. 29, 2023		3,745,000
Balance, at end of period at Jul. 29, 2023	185,916	$ 50	224,513	222,435	0	$ (261,082)
Balance, at end of period, treasury stock (in shares) at Jul. 29, 2023						1,208,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(36,811)			(36,811)
Exercise of stock options and vesting of restricted stock units (in shares)		2,000				(2,000)
Exercise of stock options and vesting of restricted stock units	0		(29)	(504)		$ 533
Share-based compensation	$ (1,141)		(1,141)
Repurchase of common stock (in shares)	0	(1,000)				1,000
Repurchase of common stock	$ (9)					$ (9)
Balance, at end of period (in shares) at Oct. 28, 2023	3,746,000	3,746,000
Balance, at end of period at Oct. 28, 2023	$ 147,955	$ 50	$ 223,343	$ 185,120	$ 0	$ (260,558)
Balance, at end of period, treasury stock (in shares) at Oct. 28, 2023	1,207,000					1,207,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (154,294)	$ (39,326)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	40,529	45,076
Loss on disposal of property and equipment	42	57
Impairment of property, equipment and lease assets	2,112	0
Share-based compensation	(4,951)	7,617
Landlord allowance amortization	(230)	(310)
Changes in operating assets and liabilities:
Receivables, net	(17,690)	(4,925)
Income tax receivable	6,222	(145)
Prepaid royalty	40,853	0
Inventories	(63,925)	(63,871)
Deferred royalty income	(16,020)	0
Accounts payable, deferred revenue, and accrued expenses	51,336	(4,865)
Other assets and liabilities	(15,351)	(35,177)
NET CASH USED IN OPERATING ACTIVITIES	(131,367)	(95,869)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(23,288)	(24,340)
Acquisition, net of cash acquired	(28,300)	0
Costs related to WHP transaction	(104)	0
NET CASH USED IN INVESTING ACTIVITIES	(51,692)	(24,340)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings under the revolving credit facility	286,250	252,000
Repayment of borrowings under the revolving credit facility	(195,606)	(143,000)
Proceeds from term loan facility	65,000	0
Repayment of borrowings under prior term loan facility	0	(3,375)
Costs incurred in connection with debt arrangements	(3,185)	0
Repurchase of common stock for tax withholding obligations	(369)	(2,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES	152,090	103,625
NET DECREASE IN CASH AND CASH EQUIVALENTS	(30,969)	(16,584)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	65,612	41,176
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 34,643	$ 24,592

Description of Business and Bas

Description of Business and Basis of Presentation	9 Months Ended
	Oct. 28, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	NOTE 1 | DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Business Description Express, Inc., together with its subsidiaries (“Express” or the “Company”), is a multi-brand fashion retailer. The Company operates an omnichannel platform, including both physical and online stores. The Company’s two brand-based operating segments are Express, which includes UpWest, and Bonobos. Brand Description Express Grounded in a belief that style, quality and value should all be found in one place, Express is a brand with a purpose - We Create Confidence. We Inspire Self-Expression . - powered by a styling community. UpWest UpWest is an apparel, accessories and home goods brand with a purpose to provide comfort for people and planet. Bonobos Bonobos is a menswear brand known for exceptional fit and an innovative retail model. As of October 28, 2023, the Company operated 600 stores in the United States and Puerto Rico, the express.com online store, the Express mobile app, the bonobos.com online store and the upwest.com online store. As of October 28, 2023, the composition of Express operated stores was as follows: Store Count Express Retail stores 324 Outlet stores 194 Edit stores 11 Total retail and outlet stores 529 UpWest 12 Bonobos 59 Total stores 600 Bonobos Acquisition On May 23, 2023, the Company completed the acquisition of the operating assets of Bonobos, a menswear brand known for exceptional fit and an innovative retail model. The acquisition is intended to expand the Company's brand portfolio and leverage the Company's fully integrated omnichannel operating platform to drive financial efficiencies, operational synergies and additional economies of scale. Refer to Note 6 for further discussion regarding the acquisition. WHP Strategic Partnership In the fourth quarter of 2022, Express closed the strategic partnership transaction with WHP Global (“WHP”), a leading global brand management firm. The mutually transformative strategic partnership advances the Company's omnichannel platform, which is expected to drive accelerated, long-term growth through the acquisition and operation of a portfolio of brands. In connection with the closing of this transaction in January 2023, the Company and WHP also formed an intellectual property joint venture (the “Joint Venture”), intended to scale the Express brand through new domestic category licensing and international expansion opportunities. Refer to Note 5 for further discussion regarding the WHP strategic partnership. Reverse Stock Split and Recasting of Per-Share Amounts On August 14, 2023, the Company’s Board of Directors (the "Board") approved the implementation of a 1-for-20 reverse stock split of the Company’s common stock, par value $0.01 per share (“Common Stock”), and a corresponding proportional reduction in the number of authorized shares of Common Stock. The reverse stock split was effected after market close on August 30, 2023 (the “Effective Date”), and shares of Common Stock began trading on a split-adjusted basis as of market open on August 31, 2023. All shares of Common Stock, stock option awards and per share amounts contained in the unaudited Consolidated Financial Statements and Notes have been retroactively adjusted to reflect the 1-for-20 reverse stock split. Refer to Note 12 for further discussion regarding the reverse stock split. Restructuring Costs On July 14, 2023 and August 17, 2023, the company announced and implemented respective phases of a workforce reduction. During the thirty-nine weeks ended October 28, 2023, in connection with the restructuring of the Company’s work force, the Company recognized $4.7 million in restructuring and related reorganization charges with $2.7 million recorded in cost of goods sold, buying and occupancy costs and $2.0 million recorded in selling, general and administrative expense in the unaudited Consolidated Statements of Income and Comprehensive Income. The charges were primarily related to employee severance and benefit costs. CEO Transition The Board appointed Stewart Glendinning as President and Chief Executive Officer of the Company effective September 15, 2023, to succeed Timothy Baxter who resigned from the Company on September 6, 2023. Fiscal Year The Company's fiscal year ends on the Saturday closest to January 31. Fiscal years are designated in the unaudited Consolidated Financial Statements and Notes, as well as the remainder of this Quarterly Report, by the calendar year in which the fiscal year commences. All references herein to the Company's fiscal years are as follows: Fiscal Year Year Ended Number of Weeks 2023 February 3, 2024 53 2022 January 28, 2023 52 All references herein to “the third quarter of 2023” and “the third quarter of 2022” represent the thirteen weeks ended October 28, 2023 and October 29, 2022, respectively. Basis of Presentation The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and the U.S. Securities and Exchange Commission’s Article 10, Regulation S-X and therefore do not include all of the information or footnotes required for complete financial statements. In the opinion of management, the accompanying unaudited Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly the financial position, results of operations, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the Company's future interim periods or 2023 fiscal year. Therefore, these statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto for the year ended January 28, 2023, included in the Annual Report. Express, Inc., through its indirect, wholly owned subsidiaries, including Express Fashion Operations, LLC, conducts the operations of the Company and Express Fashion Investments, LLC which owns a 40% economic interest with significant influence in the Joint Venture. Principles of Consolidation The unaudited Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. The Company indirectly holds a 40% equity method interest in the Joint Venture, which is majority owned by WH Borrower, LLC, an affiliate of WHP. All intercompany transactions and balances have been eliminated in consolidation. The financial results of Bonobos have been included in the unaudited Consolidated Financial Statements from the date of the completion of the acquisition on May 23, 2023. Segment Reporting The Company defines an operating segment on the same basis that it uses to evaluate performance internally. The Company has determined that its Chief Executive Officer is the Chief Operating Decision Maker, and that there are two brand-based operating segments: Express, which includes UpWest, and Bonobos. These operating segments have similar economic characteristics, classes of consumers, products, and production and distribution methods, operate in the same regulatory environments, and have been aggregated into one reportable segment. Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited Consolidated Financial Statements and the reported amounts of revenue and expense during the reporting period, as well as the related disclosure of contingent assets and liabilities as of the date of the unaudited Consolidated Financial Statements. Actual results may differ from those estimates. The Company revises its estimates and assumptions as new information becomes available. Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2023-07, S egment Reporting (Topic 280) : Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. All disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The ASU is effective for the Company’s Annual Report on Form 10-K for the fiscal year ended February 1, 2025, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures. Going Concern Assessment and Management’s Plans The Company’s revenues, results of operations and cash flows have been materially adversely impacted by negative macroeconomic factors beginning in the third and fourth quarters of 2022 and throughout 2023. The persistently challenging macroeconomic and retail apparel environments, including reduced consumer spending and increased price sensitivity in discretionary categories, have significantly impacted the Company's performance. Net sales during the thirty-nine weeks ended October 28, 2023 decreased approximately $77.2 million compared to the thirty-nine weeks ended October 29, 2022, despite the addition of $93.0 million of Bonobos net sales. This decline, coupled with aggressive promotional activity, drove gross margin and operating loss below the Company's expectations. For the thirty-nine weeks ended October 28, 2023, the Company reported a net operating loss of $138.4 million and negative operating cash flows of $131.4 million. As of October 28, 2023, the Company was in compliance with the financial covenants under the agreements governing its indebtedness, however, due to ongoing negative macroeconomic factors and their uncertain impacts on the Company’s business, results of operations and cash flows, the Company could experience further material decreases to net sales and operating cash flows and materially higher operating losses and may experience difficulty remaining in compliance with such covenants. Refer to Note 9 for further details regarding the terms of the ABL Credit Agreement (as defined therein), the Revolving Credit Facility provided to the Company thereunder and the FILO Term Loan. Under GAAP, management is required to perform an initial assessment of an entity’s ability to continue as a going concern. When conditions and events, in the aggregate, raise substantial doubt about an entity's ability to continue as a going concern, management considers the mitigating effect of its plans to the extent it is probable that the plans will be effectively implemented within the assessment period and, when implemented, it is probable the plans will mitigate the relevant conditions or events and alleviate substantial doubt. Management's plans are focused on improving its results of operations, operating cash flows and liquidity through expense reduction initiatives and improved sales trends during the balance of fiscal year 2023 and fiscal year 2024. Additionally, the Company has hired a new Chief Executive Officer and is continuing to conduct a comprehensive review of its business model to identify actions that are expected to further meaningfully reduce pre-tax costs and enable a more efficient and effective organization and has engaged external advisors to assist in this effort. Additionally, the Company has contingency plans which would further reduce or defer additional expenses and cash outlays should its results of operations weaken beyond management’s current forecasts. On September 5, 2023, the Company entered into a definitive loan agreement for a $65.0 million first-in-last-out asset-based term loan in further support of expanding liquidity access. Based on expense saving initiatives already identified and implemented for fiscal year 2023 and fiscal year 2024, including expense savings realized to date, together with the proceeds from the new FILO Term Loan (refer to Note 9 for further details regarding the terms of the FILO Term Loan), management believes these plans are being effectively implemented and, when implemented, that it is probable they will mitigate the negative impacts of the current ongoing negative macroeconomic conditions on the Company’s business. Consequently, management believes that cash flows from operations, together with borrowing capacity under the Revolving Credit Facility, will provide adequate cash flows to support the Company’s ongoing operations and to meet its obligations as they become due under the agreements governing its indebtedness for at least one year following the date these interim financial statements are issued. The accompanying unaudited Consolidated Financial Statements are prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Oct. 28, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	NOTE 2 | REVENUE RECOGNITION All revenues are recognized in net sales in the unaudited Consolidated Statements of Income and Comprehensive Income. The following is information regarding the Company’s major product categories and sales channels: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Apparel $ 411,242 $ 389,338 $ 1,150,342 $ 1,207,572 Accessories and other 26,981 31,888 80,818 103,060 Other revenue 15,840 12,919 41,504 39,217 Total net sales $ 454,063 $ 434,145 $ 1,272,664 $ 1,349,849 Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Retail $ 337,180 $ 302,652 $ 926,862 $ 943,822 Outlet 101,043 118,574 304,298 366,810 Other revenue 15,840 12,919 41,504 39,217 Total net sales $ 454,063 $ 434,145 $ 1,272,664 $ 1,349,849 Other revenue consists primarily of revenue earned from our private label credit card agreement, shipping and handling revenue related to eCommerce activity, sell-off revenue related to marked-out-of-stock inventory sales to third parties and revenue from gift card breakage. Merchandise Sales The Company recognizes sales for in-store purchases at the point-of-sale. Revenue related to eCommerce transactions is recognized upon shipment based on the fact that control transfers to the customer at that time. The Company has made a policy election to treat shipping and handling as costs to fulfill the contract, and as a result, any amounts received from customers are included in the transaction price allocated to the performance obligation of providing goods with a corresponding amount accrued within cost of goods sold, buying and occupancy costs in the unaudited Consolidated Statements of Income and Comprehensive Income for amounts paid to applicable carriers. Associate discounts on merchandise purchases are classified as a reduction of net sales. Net sales excludes sales tax collected from customers and remitted to governmental authorities. Loyalty Program The Company maintains a customer loyalty program in which customers earn points toward rewards for qualifying purchases and other marketing activities. Upon reaching specified point values, customers are issued a reward, which they may redeem on merchandise purchases at the Company’s stores or on its website. Generally, rewards earned must be redeemed within 60 days from the date of issuance. The Company defers a portion of merchandise sales based on the estimated standalone selling price of the points earned. This deferred revenue is recognized as certificates are redeemed or expire. To calculate this deferral, the Company makes assumptions related to loyalty point and certificate redemption rates based on historical experience. The loyalty liability is included in deferred revenue on the unaudited Consolidated Balance Sheets. Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Beginning balance loyalty deferred revenue $ 9,030 $ 8,754 $ 9,939 $ 10,918 Reduction in revenue/(revenue recognized) 878 462 (31) (1,702) Ending balance loyalty deferred revenue $ 9,908 $ 9,216 $ 9,908 $ 9,216 Sales Returns Reserve The Company reduces net sales and provides a reserve for projected merchandise returns based on prior experience. Merchandise returns are often resalable merchandise and are refunded by issuing the same payment tender as the original purchase. The sales returns reserve was $14.4 million and $9.0 million as of October 28, 2023 and January 28, 2023, respectively, and is included in accrued expenses on the unaudited Consolidated Balance Sheets. The asset related to projected returned merchandise is included in other assets on the unaudited Consolidated Balance Sheets. Gift Cards The Company sells gift cards in its stores, on its eCommerce website, and through third parties. These gift cards do not expire or lose value over periods of inactivity. The Company accounts for gift cards by recognizing a liability at the time a gift card is sold. The gift card liability balance was $29.4 million and $25.6 million, as of October 28, 2023 and January 28, 2023, respectively, and is included in deferred revenue on the unaudited Consolidated Balance Sheets. As part of the acquisition of Bonobos, the Company acquired $7.5 million in gift card liability. Refer to Note 6 for further discussion regarding the acquisition. During the thirteen weeks ended October 28, 2023 and October 29, 2022, the Company recognized approximately $2.4 million and $2.9 million of revenue, respectively, that was previously included in the beginning gift card contract liability. During the thirty-nine weeks ended October 28, 2023 and October 29, 2022, the Company recognized approximately $11.3 million and $10.4 million of revenue, respectively, that was previously included in the beginning gift card contract liability. The Company recognizes revenue from gift cards when they are redeemed by the customer. The Company also recognizes income on unredeemed gift cards, referred to as “gift card breakage.” Gift card breakage is recognized proportionately using a time-based attribution method from issuance of the gift card to the time when it can be determined that the likelihood of the gift card being redeemed is remote and that there is no legal obligation to remit unredeemed gift cards to relevant jurisdictions. The gift card breakage rate is based on historical redemption patterns. Gift card breakage is included within the other revenue component of net sales in the unaudited Consolidated Statements of Income and Comprehensive Income. Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Beginning gift card liability $ 30,350 $ 22,753 $ 25,604 $ 25,066 Issuances and acquired 6,497 5,575 25,205 18,188 Redemptions (6,943) (5,601) (19,479) (18,923) Gift card breakage (480) (561) (1,906) (2,165) Ending gift card liability $ 29,424 $ 22,166 $ 29,424 $ 22,166 Private Label Credit Card The Company has an agreement with Comenity Bank (the “Bank”) to provide customers with private label credit cards (as amended, the “Card Agreement”). The term of the Card Agreement expires on December 31, 2024. Each private label credit card bears the logo of the Express brand and can only be used at the Company’s store locations and eCommerce channel. The Bank is the sole owner of the accounts issued under the private label credit card program and absorbs the losses associated with non-payment by the private label card holders and a portion of any fraudulent usage of the accounts. Pursuant to the Card Agreement, the Company receives amounts from the Bank during the term based on a percentage of private label credit card sales and is also eligible to receive incentive payments for the achievement of certain performance targets. These funds are recorded within the other revenue component of net sales in the unaudited Consolidated Statements of Income and Comprehensive Income. The Company also receives reimbursement funds from the Bank for certain expenses the Company incurs. These reimbursement funds are used by the Company to fund marketing and other programs associated with the private label credit card. The reimbursement funds received related to private label credit cards are recorded within the other revenue component of net sales in the Consolidated Statements of Income and Comprehensive Income. In connection with the Card Agreement, the Bank paid the Company a $20.0 million refundable payment which the Company recognized upon receipt as deferred revenue within other long-term liabilities in the Consolidated Balance Sheets and began to recognize into income on a straight-line basis commencing January of 2018. As of October 28, 2023, the deferred revenue balance of $3.4 million will be recognized over the remaining term of the Card Agreement within the other revenue component of net sales. Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Beginning balance refundable payment liability $ 4,077 $ 6,955 $ 5,516 $ 8,394 Recognized in revenue (719) (719) (2,158) (2,158) Ending balance refundable payment liability $ 3,358 $ 6,236 $ 3,358 $ 6,236

Earnings Per Share

Earnings Per Share	9 Months Ended
	Oct. 28, 2023
Earnings Per Share [Abstract]
Earnings Per Share	NOTE 3 | EARNINGS PER SHARE The following table provides a reconciliation between basic and diluted weighted-average shares used to calculate basic and diluted earnings per share. All shares of Common Stock in the table below have been retrospectively restated to reflect the effect of the reverse stock split: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Weighted-average shares - basic 3,746 3,414 3,725 3,394 Dilutive effect of stock options and restricted stock units — — — — Weighted-average shares - diluted 3,746 3,414 3,725 3,394 Equity awards representing 0.2 million shares of Common Stock were excluded from the computation of diluted earnings per share for both the thirteen and thirty-nine weeks ended October 28, 2023, respectively, as the inclusion of these awards would have been anti-dilutive. Equity awards representing 0.2 million and 0.3 million shares of Common Stock were excluded from the computation of diluted earnings per share for the thirteen and thirty-nine weeks ended October 29, 2022, respectively, as the inclusion of these awards would have been anti-dilutive. Additionally, for the thirteen weeks ended October 28, 2023, equity awards representing 0.2 million shares of Common Stock were excluded from the computation of diluted weighted average shares because the number of shares of Common Stock that will ultimately be issued is contingent on the Company’s performance compared to pre-established performance goals which had not been achieved as of October 28, 2023.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 28, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 4 | FAIR VALUE MEASUREMENTS Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are classified using the following hierarchy, which is based upon the transparency of inputs to the valuation as of the measurement date. ■ Level 1 - Valuation is based upon quoted prices (unadjusted) for identical assets or liabilities in active markets. ■ Level 2 - Valuation is based upon quoted prices for similar assets and liabilities in active markets or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. ■ Level 3 - Valuation is based upon other unobservable inputs that are significant to the fair value measurement. Financial Assets The following table presents the Company's financial assets, recorded in cash and cash equivalents on the unaudited Consolidated Balance Sheets, measured at fair value on a recurring basis as of October 28, 2023 and January 28, 2023, aggregated by the level in the fair value hierarchy. October 28, 2023 Level 1 Level 2 Level 3 (in thousands) Money market funds $ — $ — $ — January 28, 2023 Level 1 Level 2 Level 3 (in thousands) Money market funds $ 47,792 $ — $ — The money market funds are valued using quoted market prices in active markets. Non-Financial Assets The Company's non-financial assets, which include fixtures, equipment, improvements, right of use assets, and an equity method investment, are not required to be measured at fair value on a recurring basis. However, if certain triggering events occur indicating the carrying value of these assets may not be recoverable, or annually in the case of indefinite-lived intangibles, an impairment test is required to be performed by the Company. The carrying amounts reflected on the unaudited Consolidated Balance Sheets for the remaining cash, cash equivalents, receivables, prepaid expenses, and payables as of October 28, 2023 and January 28, 2023 approximated their fair values. The equity method investment is reflected at cost and is the result of a market participant transaction with WHP whereby the Company received proceeds of $260.0 million and a 40% ownership interest in the Joint Venture in exchange for contributing certain intellectual property to the Joint Venture. The Company reviews its equity method investment by comparing its fair value to its carrying value. If the carrying value of the investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. Factors providing evidence of such a loss include changes in the investee's operations or financial condition, significant continuing losses, significant negative economic conditions or a significant decrease in the market value. Impairment charges are recorded in other expense (income), net in the unaudited Consolidated Statements of Income and Comprehensive Income. During the thirteen and thirty-nine weeks ended October 28, 2023, there were no impairment charges recorded related to equity method investments. Store Asset Impairment Property and equipment, including the right of use assets, are not required to be measured at fair value on a recurring basis. However, if certain triggering events occur indicating the carrying value of these assets may not be recoverable, an impairment test is required. These events include, but are not limited to, material adverse changes in projected revenues, present cash flow losses combined with a history of cash flow losses and a forecast that demonstrates significant continuing losses, significant negative economic conditions, a significant decrease in the market value of an asset and store closure or relocation decisions. The reviews are conducted at the store level, the lowest identifiable level of cash flow. Stores that display an indicator of impairment are subjected to an impairment assessment. Such stores are tested for recoverability by comparing the sum of the estimated future undiscounted cash flows to the carrying amount of the asset. This recoverability test requires management to make assumptions and judgments related, but not limited, to management’s expectations for future cash flows from operating the store. ▪ The key assumption used in the undiscounted future store cash flow models is the sales growth rate. An impairment loss may be recognized when these undiscounted future cash flows are less than the carrying amount of the asset group. In the circumstance of impairment, any loss would be measured as the excess of the carrying amount of the asset group over its fair value. Fair value of the store-related assets is determined at the individual store level based on the highest and best use of the asset group. ▪ The key assumptions used in the fair value analysis may include discounted estimates of future store cash flows from operating the store and/or comparable market rents. Impairment charges are recorded in cost of goods sold, buying and occupancy costs in the unaudited Consolidated Statements of Income and Comprehensive Income. During the thirteen and thirty-nine weeks ended October 28, 2023 and October 29, 2022, the Company recognized impairment charges as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Right of use asset impairment $ 812 $ — $ 1,221 $ — Property and equipment asset impairment 304 — 891 — Total asset impairment $ 1,116 $ — $ 2,112 $ —

Equity Method Investment

Equity Method Investment	9 Months Ended
	Oct. 28, 2023
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investment	NOTE 5 | EQUITY METHOD INVESTMENT The following table is a summary of the Company’s equity method investment with WHP: % of Ownership Balance Sheet Location October 28, 2023 (in thousands) EXP Topco, LLC 40% Equity Method Investment $ 166,210 The Company accounts for its 40% economic interest in the Joint Venture, through which it exercises significant influence but does not have control over the investee, under the equity method. Under the equity method, the Company records its investment in the investee on the balance sheet initially at cost, and subsequently adjusts the carrying amount based on its share of the investee's net income or loss. Royalty distributions received from the investee are recognized as a reduction of the carrying amount of the investment. The Company's share of equity (income) losses and other adjustments associated with this equity method investment is included in royalty income in the unaudited Consolidated Statements of Income and Comprehensive Income. The carrying value for the Company's equity investment is reported in Equity Method Investment on the unaudited Consolidated Balance Sheets. The Company reports its share of earnings using a one-month lag because results are not available in time for it to record them in the concurrent period. This convention has not historically materially impacted the Company's results. Equity Method Investment with WHP On January 25, 2023, the Company closed the strategic partnership transaction with WHP. In connection with the closing of this transaction, the Company and WHP formed the Joint Venture. The Company contributed certain intellectual property of the Company in exchange for 40% ownership of the Joint Venture and $235.0 million. WHP paid the $235.0 million for a 60% ownership of the Joint Venture, implying a fair value of the Company’s 40% interest in the Joint Venture of approximately $156.7 million. During the fourth quarter of 2022, under the derecognition guidance from Accounting Standards Codification ("ASC") Topic 810, Consolidation , the Company derecognized the intellectual property assets at their carrying amount upon their contribution to the Joint Venture. Because the carrying amount of the contributed intellectual property assets was zero, a $391.7 million gain was recognized at the time of contribution, of which $156.7 million was related to the Company’s 40% interest in the Joint Venture. The gain was recorded in gain on transaction with WHP on the Consolidated Statements of Income and Comprehensive Income. Transaction costs capitalized in the cost of the equity method investment totaled $9.4 million. Separately, on December 8, 2022, the Company and WH Borrower, LLC, an affiliate of WHP ("WH Borrower) entered into an investment agreement (the “Investment Agreement”) pursuant to which the Company issued and sold 5.4 million newly issued shares of Common Stock to WH Borrower in private placement for a purchase price of $4.60 per share, or an aggregate purchase price of approximately $25.0 million, representing an approximate pro forma ownership of 7.4% of the outstanding shares of Common Stock. The difference between the purchase price paid and the trading price of the Common Stock on the day of the completion of the transaction resulted in a gain of $17.8 million and was recorded in gain on transaction with WHP on the Consolidated Statements of Income and Comprehensive Income. In connection with the strategic partnership with WHP, on January 25, 2023, the Company and the Joint Venture entered into an Intellectual Property License Agreement (the “License Agreement”). The License Agreement provides the Company with an exclusive license in the United States to the intellectual property contributed in connection with the membership interest purchase agreement and certain other intellectual property. The initial term of the License Agreement is 10 years, and the License Agreement automatically renews for successive renewal terms of 10 years (unless the Company provides notice of non-renewal at least 24 months prior to the end of the initial or applicable renewal term). Except for the Company’s right not to renew the License Agreement, the License Agreement is not terminable by either party. The Company will pay the Joint Venture a royalty on net sales of certain licensed goods and will commit to an annual guaranteed minimum annual royalty during the term of the License Agreement (i.e., $60.0 million in the first contract year, increasing by $1.0 million per year for the next five Pursuant to the agreement governing the operations of the Joint Venture (the “Operating Agreement”), cash earnings of the Joint Venture will be distributed quarterly to the Company and WH Borrower on a pro rata basis based on their respective equity ownership interests. As the Chairman and Chief Executive Officer of WHP was appointed to the Company’s board of directors upon the closing of the Investment Agreement discussed above, the agreements entered into in connection with the WHP strategic partnership transaction, including the Operating Agreement, the Investment Agreement and the License Agreement (including related royalty payments) are considered related party transactions. During the thirteen and thirty-nine weeks ended October 28, 2023, the Company recognized $5.4 million and $16.0 million of royalty income, respectively, from the Joint Venture, which is recorded in royalty income in the unaudited Consolidated Statements of Income and Comprehensive Income. Summary Financial Information for Equity Method Investment Summarized financial information related to the Company's equity method investment on a one-month lag is reflected below: Thirteen Weeks Ended October 28, 2023 1 Thirty-Nine Weeks Ended October 28, 2023 1 (in thousands) Revenue $ 15,920 $ 43,643 Gross profit 15,920 43,643 Operating expenses 7,163 19,553 Interest income (50) (64) Income before taxes 8,807 24,154 Net income $ 8,455 $ 23,188 Income attributable to the equity method investment $ 5,387 $ 16,020 1. Reflects a one-month lag October 28, 2023 1 (in thousands) Current assets $ 8,651 Non-current assets 407,011 Total assets $ 415,662 Current liabilities 21,073 Non-current liabilities — Total liabilities $ 21,073 Equity method investment $ 166,210 1. Reflects a one-month lag

Acquisitions

Acquisitions	9 Months Ended
	Oct. 28, 2023
Business Combination and Asset Acquisition [Abstract]
Acquisitions	NOTE 6 | ACQUISITIONS The Company accounts for business combinations in accordance with ASC Topic 805, Business Combinations. Consistent with ASC Topic 805, the Company accounts for each business combination by applying the acquisition method. Under the acquisition method, the Company records the identifiable assets acquired and liabilities assumed at their respective fair values on the acquisition date. There are various estimates and judgments related to the valuation of identifiable assets acquired and liabilities assumed. These estimates and judgments have the potential to materially impact the Company’s unaudited Consolidated Financial Statements. The acquisition method permits the Company a period of time after the acquisition date during which the Company may adjust the provisional amounts recognized in a business combination. This period of time is referred to as the “measurement period”. The measurement period provides an acquirer with a reasonable time, generally not to exceed one year, to obtain the information necessary to identify and measure the assets acquired and liabilities assumed. If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, the Company reports in its consolidated financial statements provisional amounts for the items for which the accounting is incomplete. Accordingly, the Company is required to recognize adjustments to the provisional amounts in the reporting period in which the adjustments to the provisional amounts are determined. Thus, the Company would adjust its consolidated financial statements as needed as a result of the change to the provisional amounts calculated as if the accounting had been completed at the acquisition date. Acquisition-related costs are costs the Company incurs to affect a business combination. Those costs may include such items as finder’s fees, advisory, legal, accounting, valuation, and other professional or consulting fees, and general administrative costs. The Company accounts for such acquisition-related costs as expenses in the period in which the costs are incurred and the services are received. Bonobos Asset Acquisition On May 23, 2023, the Company completed the acquisition of the operating assets and liabilities of Bonobos, a menswear brand known for exceptional fit and an innovative retail model, for total cash consideration of approximately $28.3 million, which represents (i) the $25.0 million purchase price, plus (ii) $2.0 million of certain customary adjustments related to net working capital and $1.3 million of prepaid rent expense. The acquisition was funded with borrowings under the Revolving Credit Facility described in Note 9 . The acquisition is intended to provide the following strategic and financial benefits: • The Company plans to unlock additional growth for the Bonobos brand by leveraging its strength in men’s to address underpenetrated categories, and its strength in marketing to drive greater awareness and customer acquisition • Bonobos expands the Company's brand portfolio, accelerating the Company’s sales growth and profitability • The Company expects to leverage its fully integrated omnichannel operating platform to drive financial efficiencies, operational synergies and additional economies of scale across Production & Sourcing, Logistics, Real Estate, Technology, and other areas of its existing and new businesses Bonobos License Agreement On May 23, 2023, the Company and WHP entered into a license agreement that provides the Company with an exclusive license in the United States to intellectual property related to the Bonobos brand, including intellectual property rights for the Bonobos brand that was separately acquired by WHP (the “Bonobos License Agreement”). The Bonobos License Agreement has an initial term of 10 years from its effective date, and automatically renews for successive renewal terms of 10 years unless (i) the Company provides notice of non-renewal at least 24 months prior to the end of the initial or applicable renewal term, or (ii) WHP exercises its right to not renew in the event of certain failures by the Company to pay the annual guaranteed minimum royalty. Except for such non-renewal rights, the Bonobos License Agreement is not terminable by either party. The Company will pay WHP a royalty on net sales of certain licensed goods and is committed to pay an annual guaranteed minimum royalty during the term of the Bonobos License Agreement (ranging from $6.5 million in the first contract year to $11.5 million in the tenth contract year and each contract year thereafter). The Company will pay royalties at a rate of (i) 3.25% of net sales arising from retail sales of certain licensed goods in the first through the fifth contract years (and 3.5% thereafter), and (ii) 8% of net sales arising from wholesale sales of such goods. Refer to Note 5 for further details regarding the Company’s equity method investment with WHP. Purchase Price Allocation The Bonobos acquisition was accounted for as a business combination in accordance with ASC Topic 805 . Consistent with ASC Topic 805, Bonobos was consolidated into the Company's unaudited Consolidated Financial Statements starting on the closing date of the acquisition. The purchase price allocation as of the closing date of the acquisition was based on a preliminary valuation and is subject to change as more detailed analyses are completed and additional information about the fair value of assets acquired and liabilities assumed becomes available. The purchase price consideration was allocated to assets acquired and liabilities assumed based on their respective fair values as follows: Bonobos (in thousands) Purchase Price Cash paid $ 28,300 Allocation Receivables, net $ 2,071 Inventory 51,293 Right of use asset, net 27,914 Property and equipment, net 2,858 Other assets acquired 5,827 Assets acquired $ 89,963 Short-term lease liability (6,698) Accounts payable (9,479) Deferred revenue (9,077) Long-term lease liability (23,617) Accrued expenses and other liabilities assumed (12,792) Liabilities assumed $ (61,663) Net cash paid $ 28,300 The Company recorded an allocation of the purchase price to the tangible assets acquired and liabilities assumed based on their fair value at the acquisition date. The fair value of inventories, which is made up of finished goods, was determined based on market assumptions for realizing a reasonable profit after selling costs. Goodwill is determined as the excess of the purchase price over the fair value of the net assets acquired. The Company recognized an immaterial amount of goodwill recognized related to the acquisition. During the thirty-nine weeks ended October 28, 2023, the Company incurred $5.0 million of acquisition-related and integration costs in connection with the acquisition of Bonobos, which was included in selling, general and administrative expenses in the unaudited Consolidated Statements of Income and Comprehensive Income and are included in pro forma earnings. Pro Forma Financial Information (unaudited) The aggregate net sales and net income of Bonobos was $52.1 million and $2.1 million for the thirteen weeks ended October 28, 2023, respectively. The aggregate net sales and net income of Bonobos was $93.0 million and $4.4 million for the thirty-nine weeks ended October 28, 2023, respectively. The following financial information presents the Company's consolidated results as if the acquisition had occurred on January 30, 2022: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Net sales $ 454,063 $ 487,109 $ 1,341,684 $ 1,490,613 Net loss $ (36,811) $ (34,476) $ (160,559) $ (46,419) The Company did not have any nonrecurring pro forma adjustments directly attributable to the Bonobos acquisition included in the reported pro forma earnings and revenue. These pro forma results have been calculated after applying the Company's accounting policies. These pro forma results were based on estimates and assumptions, which the Company believes are reasonable. They are not the results that would have been realized had the acquisition actually occurred on January 30, 2022 and are not necessarily indicative of the Company's consolidated results of operations in future periods. The pro forma results include adjustments related to purchase accounting.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 28, 2023
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 7 | INCOME TAXES The provision for income taxes is based on a current estimate of the annual effective tax rate, adjusted to reflect the effect of discrete items. The Company’s effective income tax rate may fluctuate from quarter to quarter as a result of a variety of factors, including the estimate of annual pre-tax income, the related changes in the estimate, and the effect of discrete items. The impact of these items on the effective tax rate will be greater at lower pre-tax levels. The Company evaluates whether deferred tax assets are realizable on a quarterly basis. The Company considers all available positive and negative evidence, including past operating results and expectations of future operating income. Accordingly, the Company maintains a valuation allowance against the amount of deferred tax assets not expected to be realized as of October 28, 2023. The Company’s effective tax rate was (5.4)% and (2.3)% for the thirteen weeks ended October 28, 2023 and October 29, 2022, respectively. The effective tax rate for the thirteen weeks ended October 28, 2023 reflects the impact of the Company's 2022 tax return filing, the corresponding effects to a refund claim made under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), and the recording of an additional valuation allowance against the Company's current year losses. The effective tax rate for the thirteen weeks ended October 29, 2022 reflects the impact of non-deductible executive compensation and the recording of an additional valuation allowance against the Company's deferred tax assets. The Company’s effective tax rate was (1.9)% and (1.4)% for the thirty-nine weeks ended October 28, 2023 and October 29, 2022, respectively. The effective tax rate for the thirty-nine weeks ended October 28, 2023 reflects the impact of the Company's 2022 tax return filing, the corresponding effects to a refund claim made under the CARES Act, and the recording of an additional valuation allowance against the Company's current year losses. The effective tax rate for the thirty-nine weeks ended October 29, 2022 reflects the impact of non-deductible executive compensation and the recording of an additional valuation allowance against the Company's current year losses. The Company's unaudited Consolidated Balance Sheets as of October 28, 2023 and January 28, 2023 reflect $45.1 million and $52.3 million of income tax receivable related to a refund claim made under the CARES Act, respectively.

Leases

Leases	9 Months Ended
	Oct. 28, 2023
Leases [Abstract]
Leases	NOTE 8 | LEASES The Company leases all of its store locations and its corporate headquarters, which also includes its distribution center, under operating leases. The store leases typically have initial terms of 5 to 10 years; however, most of the leases that are coming to the end of their lease lives are being renegotiated with shorter terms. The current lease term for the corporate headquarters expires in 2026, with one optional five-year extension period. The Company also leases certain equipment and other assets under operating leases, typically with initial terms of 3 to 5 years. The lease term includes the initial contractual term as well as any options to extend the lease when it is reasonably certain that the Company will exercise that option. Leases with an initial term of 12 months or less (short-term leases) are not recorded on the balance sheet. The Company does not currently have any material short-term leases. The Company is generally obligated for the cost of property taxes, insurance and other landlord costs, including common area maintenance charges, relating to its leases. If these charges are fixed, they are combined with lease payments in determining the lease liability; however, if such charges are not fixed, they are considered variable lease costs and are expensed as incurred. The variable payments are not included in the measurement of the lease liability or asset. The Company’s finance leases are immaterial. Certain lease agreements include rental payments based on a percentage of retail sales over contractual levels and others include rental payments adjusted periodically for inflation. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. The Company’s lease agreements do not provide an implicit rate, so the Company uses an estimated incremental borrowing rate, which is derived from third-party information available at the lease commencement date, in determining the present value of lease payments. The rate used is for a secured borrowing of a similar term as the lease. Supplemental cash flow information related to leases is as follows: Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 (in thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 191,318 $ 189,587 Right of use assets obtained in exchange for operating lease liabilities $ 156,087 $ 39,958

Debt

Debt	9 Months Ended
	Oct. 28, 2023
Debt Disclosure [Abstract]
Debt	NOTE 9 | DEBT The following table summarizes the Company's outstanding debt as of the dates indicated: October 28, 2023 January 28, 2023 (in thousands) Revolving Credit Facility $ 212,731 $ 122,000 FILO Term Loan 65,000 — Total outstanding borrowings 277,731 122,000 Less: unamortized debt issuance costs (3,059) — Total debt, net 274,672 122,000 Less: current portion of long-term debt 4,159 — Total long-term debt, net $ 270,513 $ 122,000 Outstanding letters of credit $ 20,082 $ 19,636 Revolving Credit Facility Express, LLC (the "Borrower") and its subsidiaries are party to an Asset-Based Loan Credit Agreement (the "ABL Credit Agreement") entered into with the lenders party thereto, Wells Fargo Bank, National Association, as administrative agent and collateral agent ("Wells Fargo"), and Bank of America, N.A., as documentation agent (“Bank of America”) pursuant to which revolving loans, up to a maximum borrowing amount of $290.0 million (the “Revolving Credit Facility”), may be borrowed, repaid and reborrowed until the maturity date of November 26, 2027, at which time all amounts borrowed must be repaid. Amounts borrowed under the Revolving Credit Facility bear interest at a variable rate indexed to SOFR (as defined in the ABL Credit Agreement) plus a pricing margin ranging from 1.75% to 2.25% per annum, as determined in accordance with the provisions of the ABL Credit Agreement based on average daily excess availability, as of any date of determination, for the most recently ended fiscal quarter, commencing April 30, 2023. On September 5, 2023, the Loan Parties entered into a Fifth Amendment to the ABL Credit Agreement, which, among other things, permitted the entry by the Loan Parties into the Term Loan Agreement (defined below) on a second-priority basis to the Revolving Credit Facility. Amounts borrowed under the Revolving Credit Facility are subject to a borrowing base which is calculated based on specified percentages of eligible inventory, credit card receivables and cash, less certain reserves. Commitment reductions and termination of the Revolving Credit Facility prior to the maturity date is permitted, subject in certain instances to a prepayment fee. As of October 28, 2023, the interest rate on the approximately $212.7 million in outstanding borrowings under the Revolving Credit Facility was approximately 8.0%. The unused line fee payable under the Revolving Credit Facility is 0.25% per annum regardless of the average daily excess availability, payable in arrears monthly on the first day of each calendar month. The Borrower is also obligated to pay other customary closing fees, arrangement fees, administration fees and letter of credit fees for a credit facility of this size and type. The ABL Credit Agreement requires the Borrower to maintain minimum excess availability of at least the greater of (i) $25.0 million or (ii) 10% of the sum of the Revolving Credit Facility loan cap. From and after the date on which EBITDA (as defined in the ABL Credit Agreement) has exceeded $50.0 million for two consecutive fiscal quarters (each of which consecutive fiscal quarters shall have commenced after November 2, 2024), at any time the excess availability is less than the greater of (i) $25.0 million or (ii) 10% of the Revolving Credit Facility loan cap, and until the excess availability exceeds such amount for thirty The ABL Credit Agreement includes customary events of default that, include among other things, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, cross-default to material indebtedness, bankruptcy and insolvency defaults, material judgment defaults, ERISA defaults, structural defaults under the loan documents and a change of control default. The occurrence of an event of default could result in the acceleration of the Borrower’s obligations under the Revolving Credit Facility. Under certain circumstances, a default interest rate will apply on any amounts payable under the Revolving Credit Facility during the existence of an event of default at a per annum rate equal to 2.00% above the applicable interest rate for any principal and 2.00% above the rate applicable for base rate loans for any other interest. All obligations under the Revolving Credit Facility are guaranteed by the loan parties (other than the Borrower) and secured by a first priority lien on substantially all of the Loan Parties’ assets, subject to certain permitted liens. As of October 28, 2023, the Company had approximately $212.7 million in borrowings outstanding under the Revolving Credit Facility and approximately $21.7 million remained available for borrowing under the Revolving Credit Facility as of such date after giving effect to outstanding letters of credit in the amount of $20.1 million and subject to certain borrowing base limitations as further discussed above. The fair value of the outstanding borrowings under the Revolving Credit Facility is estimated using Level 2 inputs and at October 28, 2023 and January 28, 2023 was $201.5 million and $115.0 million, respectively. FILO Term Loan On September 5, 2023, the Company, the Borrower and certain other direct or indirect, wholly-owned subsidiaries of the Company (collectively, the “Loan Parties”) entered into an asset-based term loan agreement (the “Term Loan Agreement”) with ReStore Capital LLC, as administrative agent, collateral agent and lender, and the other lenders from time to time party thereto. The Term Loan Agreement provides the Borrower with a $65.0 million “first-in, last-out” term loan (the “FILO Term Loan”). The Borrower received $32.5 million in gross proceeds upon entering into the Term Loan Agreement, with the remaining $32.5 million principal amount from the FILO Term Loan received on September 13, 2023. The net proceeds of the FILO Term Loan were used to pay down outstanding borrowings under the ABL Credit Agreement without corresponding commitment reductions. The FILO Term Loan will mature on the earlier of (a) November 26, 2027 and (b) the date of termination of the commitments under the ABL Credit Agreement. The FILO Term Loan will bear interest at a variable rate based on the Secured Overnight Financing Rate (“SOFR”) plus an applicable margin of 10.00%. The FILO Term Loan Agreement requires the Borrower to maintain certain financial covenants and also contains customary affirmative and negative covenants and events of default. Obligations under the Term Loan Agreement are guaranteed by the Loan Parties (other than the Borrower) and secured by a second priority lien on substantially all personal property of the Loan Parties, including cash, accounts receivable, and inventory, and share the same collateral as the Revolving Credit Facility. As of October 28, 2023, the aggregate outstanding principal amount of the FILO Term Loan was $65.0 million. The fair value of the $65.0 million aggregate outstanding principal amount of the FILO Term Loan at October 28, 2023 was $40.2 million. Amounts borrowed under the FILO Term Loan will be repaid in quarterly installments, commencing with the first day of the fiscal quarter beginning on October 29, 2023, in the principal amount of $0.7 million, and thereafter, on the first day of each fiscal quarter in the principal amount of $1.2 million. All remaining principal amount of the FILO Term Loan, together with all accrued and unpaid interest, is due on the Maturity Date. Voluntary prepayment of the FILO Term Loan is permitted at any time upon proper notice, subject to a prepayment fee prior to the third anniversary of the closing date. Principal amounts repaid or prepaid under the FILO Term Loan may not be reborrowed. Amounts borrowed under the FILO Term Loan bear interest at a variable rate indexed to the SOFR plus a pricing margin of 10.0% per annum. Interest is payable monthly in arrears and due on the first day of each calendar month. As of October 28, 2023, the interest rate on the outstanding principal balance of the FILO Term Loan was 15.4%. The Term Loan Agreement requires the Borrower to maintain minimum excess availability of at least the greater of (i) $25.0 million or (ii) 10.0% of the sum of (x) the Revolving Credit Facility loan cap (calculated without giving effect to the pushdown reserve under the Term Loan Agreement) plus (y) the lesser of (A) the outstanding principal balance of the FILO Term Loan and (B) a term loan borrowing base based on specified percentages of eligible inventory and credit card receivables. In addition, the Term Loan Agreement contains customary affirmative and negative covenants, including those which (subject to certain exceptions and dollar thresholds) limit the Loan Parties’ ability to incur additional indebtedness or liens; issue negative pledges or guarantees; make investments or loans; engage in asset sales, mergers, acquisitions; prepay other debt; make distributions, pay dividends or repurchase capital stock; engage in transactions with affiliates; and engage in any line of business not related to their current line of business. The Term Loan Agreement also includes customary events of default that include, among other things, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, cross-default to material indebtedness, bankruptcy and insolvency defaults, material judgment defaults, ERISA defaults, structural defaults under the loan documents and a change of control default. The occurrence of an event of default could result in the acceleration of the obligations under the Term Loan Agreement. Under certain circumstances, a default interest rate will apply on any amount payable under the Term Loan Agreement during the existence of an event of default at a per annum rate equal to 3.0% above the otherwise then applicable interest rate. All obligations under the Term Loan Agreement are guaranteed by the Loan Parties (other than the Borrower) and secured by a second priority lien on substantially all personal property of the Loan Parties, including cash, accounts receivable, and inventory, and share the same collateral as the Revolving Credit Facility. The Company recorded deferred financing costs associated with the issuance of the FILO Term Loan. The unamortized balance of such deferred costs was $3.1 million as of October 28, 2023. These costs will be amortized over the respective contractual terms of the Term Loan Agreement or written off ratably as the outstanding principal balance under the FILO Term Loan is extinguished. The aggregate outstanding principal amount of the FILO Term Loan is presented on the Consolidated Balance Sheets, net of the unamortized fees. Letters of Credit From time to time, the Company may enter into various trade letters of credit ("trade LCs") in favor of certain vendors to secure merchandise. These trade LCs are issued for a defined period of time, for specific shipments, and generally expire three weeks after the merchandise shipment date. As of October 28, 2023 and January 28, 2023, there were no outstanding trade LCs. Additionally, the Company enters into stand-by letters of credit ("stand-by LCs") on an as-needed basis to secure payment obligations for third party logistic services, merchandise purchases, and other general and administrative expenses. As of October 28, 2023 and January 28, 2023, outstanding stand-by LCs totaled $20.1 million and $19.6 million, respectively.

Long-Term Incentive Compensatio

Long-Term Incentive Compensation	9 Months Ended
	Oct. 28, 2023
Share-Based Payment Arrangement [Abstract]
Long-Term Incentive Compensation	NOTE 10 | LONG-TERM INCENTIVE COMPENSATION The Company records the fair value of share-based payments to employees in the unaudited Consolidated Statements of Income and Comprehensive Income as compensation expense, net of forfeitures, over the requisite service period. The Company issues shares of Common Stock from treasury, at average cost, upon exercise of stock options and vesting of restricted stock units, including those with performance conditions. Long-Term Incentive Compensation The following summarizes long-term incentive compensation expense: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Restricted stock units $ 23 $ 1,015 $ 869 $ 3,292 Stock options — 88 161 263 Performance-based restricted stock units (1,164) 1,501 (5,981) 4,062 Total share-based compensation $ (1,141) $ 2,604 $ (4,951) $ 7,617 Cash-settled awards 785 3,449 6,286 9,594 Total long-term incentive compensation $ (356) $ 6,053 $ 1,335 $ 17,211 The stock compensation related income tax benefit, excluding consideration of valuation allowances, recognized by the Company during the thirteen weeks ended October 28, 2023 was $0.1 million. The stock compensation related income tax benefit, excluding consideration of valuation allowances, recognized by the Company during the thirty-nine weeks ended October 28, 2023 was $4.2 million. The stock compensation related income tax benefit, excluding consideration of valuation allowances, recognized by the Company during the thirteen and thirty-nine weeks ended October 29, 2022 was $0.1 million and $3.0 million, respectively. The valuation allowance associated with the tax benefit for the thirteen weeks ended October 28, 2023 was $0.1 million. The valuation allowance associated with the tax benefit for the thirty-nine weeks ended October 28, 2023 was $4.2 million. The valuation allowances associated with these tax benefits were $0.1 million and $3.0 million for the thirteen and thirty-nine weeks ended October 29, 2022, respectively. Equity Awards Restricted Stock Units During the thirty-nine weeks ended October 28, 2023, the Company granted restricted stock units (“RSUs”) under the Second Amended and Restated Express, Inc. 2018 Incentive Compensation Plan (the "Plan"). The fair value of RSUs is generally determined based on the Company’s closing stock price on the day prior to the grant date in accordance with the Plan. The RSUs granted generally vest ratably over one The Company’s activity with respect to RSUs for the thirty-nine weeks ended October 28, 2023 was as follows: Number of Shares Grant Date (in thousands, except per share amounts) Unvested - January 28, 2023 87 $ 45.38 Granted 1 $ 22.80 Vested (80) $ 44.01 Forfeited (6) $ 59.98 Unvested - October 28, 2023 2 $ 57.91 The total fair value of RSUs that vested during the thirty-nine weeks ended October 28, 2023 and October 29, 2022 was $3.5 million and $5.2 million, respectively. As of October 28, 2023, there was approximately $0.1 million of total unrecognized compensation expense related to unvested RSUs, which is expected to be recognized over a remaining weighted-average period of approximately 1.1 years. Stock Options The Company’s activity with respect to stock options during the thirty-nine weeks ended October 28, 2023 was as follows: Number of Shares Grant Date Weighted-Average Remaining Contractual Life (in years) Aggregate Intrinsic Value (in thousands, except per share amounts and years) Outstanding - January 28, 2023 143 $ 96.86 Granted — $ — Exercised — $ — Forfeited or expired (6) $ 335.40 Outstanding - October 28, 2023 137 $ 87.47 5.2 $ — Expected to vest at October 28, 2023 — $ — 0 $ — Exercisable at October 28, 2023 137 $ 87.47 5.2 $ — As of October 28, 2023, there was no unrecognized compensation expense related to stock options. Performance-Based Restricted Stock Units During 2022, the Company granted performance-based RSUs to a limited number of senior executive-level employees, which entitle these employees to receive a specified number of shares of the Common Stock upon vesting based upon the achievement of certain performance conditions. The number of shares of Common Stock earned could range between 0% and 200% of the target amount of shares underlying the award depending upon performance achieved over a three-year performance period. The performance conditions of the awards include adjusted earnings before interest, taxes, depreciation, and amortization ("Adjusted EBITDA") targets and the Company's total shareholder return ("TSR") relative to a select group of peer companies. A Monte Carlo valuation model was used to determine the fair value of the awards. The TSR performance condition is a market condition. Therefore, the fair value of the portion of the awards which vest based on the TSR performance condition is fixed at the measurement date and is not revised based on actual performance during the three-year vesting period. The number of shares of Common Stock underlying the portion of the awards which vest based on the Company’s Adjusted EBITDA performance in relation to the pre-established targets will change during the three-year vesting period based on estimates. During the thirteen weeks ended October 28, 2023, as a material inducement to accept employment with the Company, the Company granted its new Chief Executive Officer an award consisting of 0.15 million performance-based RSUs. The RSUs will become eligible to vest (with a maximum payout of 200% of target) on the last day of fiscal year 2026 based on the Company’s average stock price performance, relative to a pre-determined goal, during the period between the grant date and the last day of fiscal year 2026. A Monte Carlo valuation model was used to determine the fair value of the inducement award. Because the stock price performance condition is a market condition, the fair value the award is measured and fixed at the grant date and is not revised based on actual performance during the performance period. As of October 28, 2023, $0.3 million of total unrecognized compensation cost is expected to be recognized on outstanding performance-based RSUs over a remaining weighted-average period of 3.3 years. Cash-Settled Awards Time-Based Cash-Settled Awards During the thirty-nine weeks ended October 28, 2023, the Company granted time-based cash-settled awards to employees that vest ratably over three years. These awards are classified as liabilities and do not vary based on changes in the Company's stock price or financial performance. The expense related to these awards will be accrued using a straight-line method over this vesting period. As of October 28, 2023, $9.8 million of total unrecognized compensation cost is expected to be recognized on outstanding cash-settled awards over a remaining weighted-average period of 1.4 years. Performance-Based Cash-Settled Awards During the thirty-nine weeks ended October 28, 2023, the Company granted performance-based cash-settled awards to a limited number of senior executive-level employees. These awards are classified as liabilities, are valued based on the fair value of the award at the grant date and are remeasured at each reporting date until settlement with compensation expense being recognized in proportion to the completed requisite service period up until date of settlement. The amount of cash earned ranges between 0% and 200% of the target amount depending upon performance achieved over a three-year performance period commencing on the first day of the Company’s 2023 fiscal year and ending on the last day of the Company’s 2025 fiscal year. The performance conditions of the award include Adjusted EBITDA targets and the Company's TSR relative to a select group of peer companies. The fair value of the awards will change based on estimates of the Company’s Adjusted EBITDA performance in relation to the pre-established targets. A Monte Carlo valuation model was used to determine the fair value of the awards. As of October 28, 2023, $1.3 million of total unrecognized compensation cost is expected to be recognized on outstanding performance-based cash-settled awards over a remaining weighted-average period of 2.5 years.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 28, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 11 | COMMITMENTS AND CONTINGENCIES The Company is presently, and from time to time, subject to various claims and contingencies arising in the normal course of its business. The Company currently believes that the ultimate liability arising from such claims and contingencies, if any, is not likely to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. In a complaint filed in January 2017 by Mr. Jorge Chacon in the Superior Court for the State of California for the County of Orange, certain subsidiaries of the Company were named as defendants in a representative action alleging violations of California state wage and hour statutes and other labor standards. The lawsuit sought unspecified monetary damages and attorneys’ fees. In July 2018, former associate Ms. Christie Carr filed suit in Alameda County Superior Court for the State of California naming certain subsidiaries of the Company as defendants in a representative action alleging violations of California State wage and hour statutes and other labor standard violations. The lawsuit sought unspecified monetary damages and attorneys’ fees. On January 29, 2019, Mr. Jorge Chacon filed a second representative action in the Superior Court for the State of California for the County of Orange alleging violations of California state wage and hour statutes and other labor standard violations, which was removed to federal court by the Company. The lawsuit sought unspecified monetary damages and attorneys' fees. In June 2021, a portion of Mr. Chacon’s claims in this action were certified as a class action. The plaintiff and the Company both filed Motions for Summary Judgment on February 28, 2022. In June 2022, as a result of a mediation process overseen by an independent mediator, the parties agreed, subject to approval by the District Court, to settle these matters for an amount not material to the Company. The proposed settlement will resolve the Chacon and Carr matters in their entirety and also provide for a broad release of claims asserted therein on behalf of the Company’s current and former employees in California for wage and hour violations. On August 18, 2023, the Court granted preliminary approval of the settlement. A final approval hearing is scheduled in January 2024. Any legal proceedings are subject to inherent uncertainties, and the Company’s view of these matters and their potential effects may change in the future. In accordance with applicable accounting standards, the Company establishes an accrued liability for loss contingencies related to legal proceedings when the loss is both probable and reasonably estimable. As of October 28, 2023, the Company's unaudited Consolidated Balance Sheet includes an estimated liability based on its best estimate of the outcome of the unresolved matters.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 28, 2023
Equity [Abstract]
Stockholders' Equity	NOTE 12 | STOCKHOLDERS' EQUITY Share Repurchase Program On November 28, 2017, the Company's Board of Directors ("Board") approved a share repurchase program that authorizes the Company to repurchase up to $150.0 million of Common Stock using available cash (the "Repurchase Program"). The Company may repurchase shares on the open market, including through Rule 10b5-1 plans, in privately negotiated transactions, through block purchases, or otherwise in compliance with applicable laws, including Rule 10b-18 of the Exchange Act of 1934, as amended (the "Exchange Act"). The timing and amount of stock repurchases will depend on a variety of factors, including business and market conditions as well as corporate and regulatory considerations. The Repurchase Program may be suspended, modified, or discontinued at any time and the Company has no obligation to repurchase any amount of Common Stock under the program. During the thirteen and thirty-nine weeks ended October 28, 2023 and October 29, 2022, the Company did not repurchase any shares of Common Stock. As of October 28, 2023, the Company had approximately $34.2 million remaining under this Board authorization. Reverse Stock Split On August 30, 2023, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split of the Common Stock. Pursuant to the Certificate of Amendment, effective as of 5:00 p.m., Eastern Time, on August 30, 2023, (i) every 20 shares of Common Stock issued and outstanding, including shares of Common Stock held by the Company as treasury shares, were automatically combined into one share of Common Stock, and (ii) the number of authorized shares of Common Stock was reduced from 500.0 million authorized shares to 25.0 million authorized shares of Common Stock. The Company’s stockholders of record will receive a cash payment (without interest) in lieu of any fractional shares they would have otherwise been entitled to receive in the reverse stock split. Shares of the Common Stock began trading on a split-adjusted basis at market open on August 31, 2023. Shares of the Common Stock continue to trade on New York Stock Exchange ("NYSE") under the symbol “EXPR” with the CUSIP number, 30219E 202. Based on the resulting increase in the per share trading price of the Common Stock following the implementation of the reverse stock split, on September 11, 2023, the Company was notified that it had regained compliance with the minimum price criteria set forth in the continued listing standards of the NYSE. The $0.01 par value per share of Common Stock and any other rights associated the Common Stock were not affected by the reverse stock split. All shares of Common Stock, stock option awards and per share amounts in the accompanying unaudited Consolidated Financial Statements and related Notes have been retrospectively restated to reflect the effect of the reverse stock split. Preferred shares outstanding were not affected by the reverse stock split and as such, those shares have not been adjusted.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 28, 2023	Oct. 29, 2022
Pay vs Performance Disclosure
Net loss	$ (36,811)	$ (44,056)	$ (73,427)	$ (34,448)	$ 7,036	$ (11,914)	$ (154,294)	$ (39,326)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 28, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Description of Business and B_2

Description of Business and Basis of Presentation (Policies)	9 Months Ended
	Oct. 28, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Year	Fiscal Year The Company's fiscal year ends on the Saturday closest to January 31. Fiscal years are designated in the unaudited Consolidated Financial Statements and Notes, as well as the remainder of this Quarterly Report, by the calendar year in which the fiscal year commences. All references herein to the Company's fiscal years are as follows: Fiscal Year Year Ended Number of Weeks 2023 February 3, 2024 53 2022 January 28, 2023 52 All references herein to “the third quarter of 2023” and “the third quarter of 2022” represent the thirteen weeks ended October 28, 2023 and October 29, 2022, respectively.
Basis of Presentation	Basis of Presentation The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and the U.S. Securities and Exchange Commission’s Article 10, Regulation S-X and therefore do not include all of the information or footnotes required for complete financial statements. In the opinion of management, the accompanying unaudited Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly the financial position, results of operations, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the Company's future interim periods or 2023 fiscal year. Therefore, these statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto for the year ended January 28, 2023, included in the Annual Report. Express, Inc., through its indirect, wholly owned subsidiaries, including Express Fashion Operations, LLC, conducts the operations of the Company and Express Fashion Investments, LLC which owns a 40% economic interest with significant influence in the Joint Venture.
Principles of Consolidation	Principles of Consolidation
Segment Reporting	Segment Reporting
Use of Estimates in the Preparation of Financial Statements	Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited Consolidated Financial Statements and the reported amounts of revenue and expense during the reporting period, as well as the related disclosure of contingent assets and liabilities as of the date of the unaudited Consolidated Financial Statements. Actual results may differ from those estimates. The Company revises its estimates and assumptions as new information becomes available.
Accounting Pronouncements Not Yet Adopted	Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2023-07, S egment Reporting (Topic 280) : Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. All disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The ASU is effective for the Company’s Annual Report on Form 10-K for the fiscal year ended February 1, 2025, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.
Revenue Recognition	Merchandise Sales The Company recognizes sales for in-store purchases at the point-of-sale. Revenue related to eCommerce transactions is recognized upon shipment based on the fact that control transfers to the customer at that time. The Company has made a policy election to treat shipping and handling as costs to fulfill the contract, and as a result, any amounts received from customers are included in the transaction price allocated to the performance obligation of providing goods with a corresponding amount accrued within cost of goods sold, buying and occupancy costs in the unaudited Consolidated Statements of Income and Comprehensive Income for amounts paid to applicable carriers. Associate discounts on merchandise purchases are classified as a reduction of net sales. Net sales excludes sales tax collected from customers and remitted to governmental authorities. Loyalty Program The Company maintains a customer loyalty program in which customers earn points toward rewards for qualifying purchases and other marketing activities. Upon reaching specified point values, customers are issued a reward, which they may redeem on merchandise purchases at the Company’s stores or on its website. Generally, rewards earned must be redeemed within 60 days from the date of issuance. The Company defers a portion of merchandise sales based on the estimated standalone selling price of the points earned. This deferred revenue is recognized as certificates are redeemed or expire. To calculate this deferral, the Company makes assumptions related to loyalty point and certificate redemption rates based on historical experience. The loyalty liability is included in deferred revenue on the unaudited Consolidated Balance Sheets. Sales Returns Reserve The Company reduces net sales and provides a reserve for projected merchandise returns based on prior experience. Merchandise returns are often resalable merchandise and are refunded by issuing the same payment tender as the original purchase. The sales returns reserve was $14.4 million and $9.0 million as of October 28, 2023 and January 28, 2023, respectively, and is included in accrued expenses on the unaudited Consolidated Balance Sheets. The asset related to projected returned merchandise is included in other assets on the unaudited Consolidated Balance Sheets. Gift Cards The Company sells gift cards in its stores, on its eCommerce website, and through third parties. These gift cards do not expire or lose value over periods of inactivity. The Company accounts for gift cards by recognizing a liability at the time a gift card is sold. The gift card liability balance was $29.4 million and $25.6 million, as of October 28, 2023 and January 28, 2023, respectively, and is included in deferred revenue on the unaudited Consolidated Balance Sheets. As part of the acquisition of Bonobos, the Company acquired $7.5 million in gift card liability. Refer to Note 6 for further discussion regarding the acquisition. During the thirteen weeks ended October 28, 2023 and October 29, 2022, the Company recognized approximately $2.4 million and $2.9 million of revenue, respectively, that was previously included in the beginning gift card contract liability. During the thirty-nine weeks ended October 28, 2023 and October 29, 2022, the Company recognized approximately $11.3 million and $10.4 million of revenue, respectively, that was previously included in the beginning gift card contract liability. The Company recognizes revenue from gift cards when they are redeemed by the customer. The Company also recognizes income on unredeemed gift cards, referred to as “gift card breakage.” Gift card breakage is recognized proportionately using a time-based attribution method from issuance of the gift card to the time when it can be determined that the likelihood of the gift card being redeemed is remote and that there is no legal obligation to remit unredeemed gift cards to relevant jurisdictions. The gift card breakage rate is based on historical redemption patterns. Gift card breakage is included within the other revenue component of net sales in the unaudited Consolidated Statements of Income and Comprehensive Income. Private Label Credit Card The Company has an agreement with Comenity Bank (the “Bank”) to provide customers with private label credit cards (as amended, the “Card Agreement”). The term of the Card Agreement expires on December 31, 2024. Each private label credit card bears the logo of the Express brand and can only be used at the Company’s store locations and eCommerce channel. The Bank is the sole owner of the accounts issued under the private label credit card program and absorbs the losses associated with non-payment by the private label card holders and a portion of any fraudulent usage of the accounts. Pursuant to the Card Agreement, the Company receives amounts from the Bank during the term based on a percentage of private label credit card sales and is also eligible to receive incentive payments for the achievement of certain performance targets. These funds are recorded within the other revenue component of net sales in the unaudited Consolidated Statements of Income and Comprehensive Income. The Company also receives reimbursement funds from the Bank for certain expenses the Company incurs. These reimbursement funds are used by the Company to fund marketing and other programs associated with the private label credit card. The reimbursement funds received related to private label credit cards are recorded within the other revenue component of net sales in the Consolidated Statements of Income and Comprehensive Income.
Fair Value Measurements	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are classified using the following hierarchy, which is based upon the transparency of inputs to the valuation as of the measurement date. ■ Level 1 - Valuation is based upon quoted prices (unadjusted) for identical assets or liabilities in active markets. ■ Level 2 - Valuation is based upon quoted prices for similar assets and liabilities in active markets or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. ■ Level 3 - Valuation is based upon other unobservable inputs that are significant to the fair value measurement. The money market funds are valued using quoted market prices in active markets. Non-Financial Assets The Company's non-financial assets, which include fixtures, equipment, improvements, right of use assets, and an equity method investment, are not required to be measured at fair value on a recurring basis. However, if certain triggering events occur indicating the carrying value of these assets may not be recoverable, or annually in the case of indefinite-lived intangibles, an impairment test is required to be performed by the Company. The carrying amounts reflected on the unaudited Consolidated Balance Sheets for the remaining cash, cash equivalents, receivables, prepaid expenses, and payables as of October 28, 2023 and January 28, 2023 approximated their fair values. The equity method investment is reflected at cost and is the result of a market participant transaction with WHP whereby the Company received proceeds of $260.0 million and a 40% ownership interest in the Joint Venture in exchange for contributing certain intellectual property to the Joint Venture. The Company reviews its equity method investment by comparing its fair value to its carrying value. If the carrying value of the investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. Factors providing evidence of such a loss include changes in the investee's operations or financial condition, significant continuing losses, significant negative economic conditions or a significant decrease in the market value. Impairment charges are recorded in other expense (income), net in the unaudited Consolidated Statements of Income and Comprehensive Income. During the thirteen and thirty-nine weeks ended October 28, 2023, there were no impairment charges recorded related to equity method investments. Store Asset Impairment Property and equipment, including the right of use assets, are not required to be measured at fair value on a recurring basis. However, if certain triggering events occur indicating the carrying value of these assets may not be recoverable, an impairment test is required. These events include, but are not limited to, material adverse changes in projected revenues, present cash flow losses combined with a history of cash flow losses and a forecast that demonstrates significant continuing losses, significant negative economic conditions, a significant decrease in the market value of an asset and store closure or relocation decisions. The reviews are conducted at the store level, the lowest identifiable level of cash flow. Stores that display an indicator of impairment are subjected to an impairment assessment. Such stores are tested for recoverability by comparing the sum of the estimated future undiscounted cash flows to the carrying amount of the asset. This recoverability test requires management to make assumptions and judgments related, but not limited, to management’s expectations for future cash flows from operating the store. ▪ The key assumption used in the undiscounted future store cash flow models is the sales growth rate. An impairment loss may be recognized when these undiscounted future cash flows are less than the carrying amount of the asset group. In the circumstance of impairment, any loss would be measured as the excess of the carrying amount of the asset group over its fair value. Fair value of the store-related assets is determined at the individual store level based on the highest and best use of the asset group. ▪ The key assumptions used in the fair value analysis may include discounted estimates of future store cash flows from operating the store and/or comparable market rents.
Leases	The lease term includes the initial contractual term as well as any options to extend the lease when it is reasonably certain that the Company will exercise that option. Leases with an initial term of 12 months or less (short-term leases) are not recorded on the balance sheet. The Company does not currently have any material short-term leases. The Company is generally obligated for the cost of property taxes, insurance and other landlord costs, including common area maintenance charges, relating to its leases. If these charges are fixed, they are combined with lease payments in determining the lease liability; however, if such charges are not fixed, they are considered variable lease costs and are expensed as incurred. The variable payments are not included in the measurement of the lease liability or asset. The Company’s finance leases are immaterial. Certain lease agreements include rental payments based on a percentage of retail sales over contractual levels and others include rental payments adjusted periodically for inflation. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. The Company’s lease agreements do not provide an implicit rate, so the Company uses an estimated incremental borrowing rate, which is derived from third-party information available at the lease commencement date, in determining the present value of lease payments. The rate used is for a secured borrowing of a similar term as the lease.
Share-Based Compensation	The Company records the fair value of share-based payments to employees in the unaudited Consolidated Statements of Income and Comprehensive Income as compensation expense, net of forfeitures, over the requisite service period. The Company issues shares of Common Stock from treasury, at average cost, upon exercise of stock options and vesting of restricted stock units, including those with performance conditions.

Description of Business and B_3

Description of Business and Basis of Presentation (Tables)	9 Months Ended
	Oct. 28, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Composition of Operated Stores	As of October 28, 2023, the composition of Express operated stores was as follows: Store Count Express Retail stores 324 Outlet stores 194 Edit stores 11 Total retail and outlet stores 529 UpWest 12 Bonobos 59 Total stores 600

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Oct. 28, 2023
Revenue from Contract with Customer [Abstract]
Revenue by Major Product Categories and Sales Channels	The following is information regarding the Company’s major product categories and sales channels: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Apparel $ 411,242 $ 389,338 $ 1,150,342 $ 1,207,572 Accessories and other 26,981 31,888 80,818 103,060 Other revenue 15,840 12,919 41,504 39,217 Total net sales $ 454,063 $ 434,145 $ 1,272,664 $ 1,349,849 Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Retail $ 337,180 $ 302,652 $ 926,862 $ 943,822 Outlet 101,043 118,574 304,298 366,810 Other revenue 15,840 12,919 41,504 39,217 Total net sales $ 454,063 $ 434,145 $ 1,272,664 $ 1,349,849
Contract with Customer, Liability	Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Beginning balance loyalty deferred revenue $ 9,030 $ 8,754 $ 9,939 $ 10,918 Reduction in revenue/(revenue recognized) 878 462 (31) (1,702) Ending balance loyalty deferred revenue $ 9,908 $ 9,216 $ 9,908 $ 9,216 Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Beginning gift card liability $ 30,350 $ 22,753 $ 25,604 $ 25,066 Issuances and acquired 6,497 5,575 25,205 18,188 Redemptions (6,943) (5,601) (19,479) (18,923) Gift card breakage (480) (561) (1,906) (2,165) Ending gift card liability $ 29,424 $ 22,166 $ 29,424 $ 22,166 Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Beginning balance refundable payment liability $ 4,077 $ 6,955 $ 5,516 $ 8,394 Recognized in revenue (719) (719) (2,158) (2,158) Ending balance refundable payment liability $ 3,358 $ 6,236 $ 3,358 $ 6,236

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Oct. 28, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table provides a reconciliation between basic and diluted weighted-average shares used to calculate basic and diluted earnings per share. All shares of Common Stock in the table below have been retrospectively restated to reflect the effect of the reverse stock split: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Weighted-average shares - basic 3,746 3,414 3,725 3,394 Dilutive effect of stock options and restricted stock units — — — — Weighted-average shares - diluted 3,746 3,414 3,725 3,394

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 28, 2023
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis	The following table presents the Company's financial assets, recorded in cash and cash equivalents on the unaudited Consolidated Balance Sheets, measured at fair value on a recurring basis as of October 28, 2023 and January 28, 2023, aggregated by the level in the fair value hierarchy. October 28, 2023 Level 1 Level 2 Level 3 (in thousands) Money market funds $ — $ — $ — January 28, 2023 Level 1 Level 2 Level 3 (in thousands) Money market funds $ 47,792 $ — $ —
Impairment Charges	During the thirteen and thirty-nine weeks ended October 28, 2023 and October 29, 2022, the Company recognized impairment charges as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Right of use asset impairment $ 812 $ — $ 1,221 $ — Property and equipment asset impairment 304 — 891 — Total asset impairment $ 1,116 $ — $ 2,112 $ —

Equity Method Investment (Table

Equity Method Investment (Tables)	9 Months Ended
	Oct. 28, 2023
Equity Method Investments and Joint Ventures [Abstract]
Schedule of Equity Method Investments	The following table is a summary of the Company’s equity method investment with WHP: % of Ownership Balance Sheet Location October 28, 2023 (in thousands) EXP Topco, LLC 40% Equity Method Investment $ 166,210 Summarized financial information related to the Company's equity method investment on a one-month lag is reflected below: Thirteen Weeks Ended October 28, 2023 1 Thirty-Nine Weeks Ended October 28, 2023 1 (in thousands) Revenue $ 15,920 $ 43,643 Gross profit 15,920 43,643 Operating expenses 7,163 19,553 Interest income (50) (64) Income before taxes 8,807 24,154 Net income $ 8,455 $ 23,188 Income attributable to the equity method investment $ 5,387 $ 16,020 1. Reflects a one-month lag October 28, 2023 1 (in thousands) Current assets $ 8,651 Non-current assets 407,011 Total assets $ 415,662 Current liabilities 21,073 Non-current liabilities — Total liabilities $ 21,073 Equity method investment $ 166,210 1. Reflects a one-month lag

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Oct. 28, 2023
Business Combination and Asset Acquisition [Abstract]
Recognized Identified Assets Acquired and Liabilities Assumed	The purchase price consideration was allocated to assets acquired and liabilities assumed based on their respective fair values as follows: Bonobos (in thousands) Purchase Price Cash paid $ 28,300 Allocation Receivables, net $ 2,071 Inventory 51,293 Right of use asset, net 27,914 Property and equipment, net 2,858 Other assets acquired 5,827 Assets acquired $ 89,963 Short-term lease liability (6,698) Accounts payable (9,479) Deferred revenue (9,077) Long-term lease liability (23,617) Accrued expenses and other liabilities assumed (12,792) Liabilities assumed $ (61,663) Net cash paid $ 28,300
Pro Forma Information	The following financial information presents the Company's consolidated results as if the acquisition had occurred on January 30, 2022: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Net sales $ 454,063 $ 487,109 $ 1,341,684 $ 1,490,613 Net loss $ (36,811) $ (34,476) $ (160,559) $ (46,419)

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 28, 2023
Leases [Abstract]
Supplemental Cash Flow Information on Leases	Supplemental cash flow information related to leases is as follows: Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 (in thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 191,318 $ 189,587 Right of use assets obtained in exchange for operating lease liabilities $ 156,087 $ 39,958

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 28, 2023
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	The following table summarizes the Company's outstanding debt as of the dates indicated: October 28, 2023 January 28, 2023 (in thousands) Revolving Credit Facility $ 212,731 $ 122,000 FILO Term Loan 65,000 — Total outstanding borrowings 277,731 122,000 Less: unamortized debt issuance costs (3,059) — Total debt, net 274,672 122,000 Less: current portion of long-term debt 4,159 — Total long-term debt, net $ 270,513 $ 122,000 Outstanding letters of credit $ 20,082 $ 19,636

Long-Term Incentive Compensat_2

Long-Term Incentive Compensation (Tables)	9 Months Ended
	Oct. 28, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Shared-based Compensation Expense	The following summarizes long-term incentive compensation expense: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2023 October 29, 2022 October 28, 2023 October 29, 2022 (in thousands) Restricted stock units $ 23 $ 1,015 $ 869 $ 3,292 Stock options — 88 161 263 Performance-based restricted stock units (1,164) 1,501 (5,981) 4,062 Total share-based compensation $ (1,141) $ 2,604 $ (4,951) $ 7,617 Cash-settled awards 785 3,449 6,286 9,594 Total long-term incentive compensation $ (356) $ 6,053 $ 1,335 $ 17,211
Schedule of Activity Related to Restricted Stock Units,	The Company’s activity with respect to RSUs for the thirty-nine weeks ended October 28, 2023 was as follows: Number of Shares Grant Date (in thousands, except per share amounts) Unvested - January 28, 2023 87 $ 45.38 Granted 1 $ 22.80 Vested (80) $ 44.01 Forfeited (6) $ 59.98 Unvested - October 28, 2023 2 $ 57.91
Schedule of Activity Related to Stock Options	The Company’s activity with respect to stock options during the thirty-nine weeks ended October 28, 2023 was as follows: Number of Shares Grant Date Weighted-Average Remaining Contractual Life (in years) Aggregate Intrinsic Value (in thousands, except per share amounts and years) Outstanding - January 28, 2023 143 $ 96.86 Granted — $ — Exercised — $ — Forfeited or expired (6) $ 335.40 Outstanding - October 28, 2023 137 $ 87.47 5.2 $ — Expected to vest at October 28, 2023 — $ — 0 $ — Exercisable at October 28, 2023 137 $ 87.47 5.2 $ —

Description of Business and B_4

Description of Business and Basis of Presentation - Narrative (Details) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Aug. 30, 2023 $ / shares	Oct. 28, 2023 USD ($) store $ / shares	Oct. 29, 2022 USD ($)	Oct. 28, 2023 USD ($) segment store $ / shares	Oct. 29, 2022 USD ($)	Sep. 05, 2023 USD ($)	Aug. 14, 2023 $ / shares	Jan. 28, 2023 USD ($) $ / shares	Jan. 25, 2023
Description of Business and Basis of Presentation [Line Items]
Number of operating segments | segment				2
Number of stores | store		600		600
Common stock, par value (in USD per share) | $ / shares	$ 0.01	$ 0.01		$ 0.01			$ 0.01	$ 0.01
Restructuring and related reorganization charges				$ 4,700
Number of reportable segments | segment				1
Decrease in sales from comparable quarter in prior year				$ 77,200
Operating loss		$ 28,742	$ 29,509	138,428	$ 28,200
Negative operating cash flows				131,367	$ 95,869
Total outstanding borrowings		277,731		277,731				$ 122,000
Cost Of Revenue
Description of Business and Basis of Presentation [Line Items]
Restructuring and related reorganization charges				2,700
Selling, General and Administrative Expenses
Description of Business and Basis of Presentation [Line Items]
Restructuring and related reorganization charges				2,000
Secured Debt | Term Loan Agreement | Line of Credit
Description of Business and Basis of Presentation [Line Items]
Total outstanding borrowings		65,000		65,000		$ 65,000		$ 0
Bonobos
Description of Business and Basis of Presentation [Line Items]
Aggregate net sales		$ 52,100		$ 93,000
Common Stock
Description of Business and Basis of Presentation [Line Items]
Reverse stock split, conversion ratio	0.05
EXP Topco LLC
Description of Business and Basis of Presentation [Line Items]
Equity method investment, ownership percentage		40%		40%				40%	40%

Description of Business and B_5

Description of Business and Basis of Presentation - Composition of Operated Stores (Details)	Oct. 28, 2023 store
Description of Business and Basis of Presentation [Line Items]
Number of stores	600
Total retail and outlet stores
Description of Business and Basis of Presentation [Line Items]
Number of stores	529
Retail stores
Description of Business and Basis of Presentation [Line Items]
Number of stores	324
Outlet stores
Description of Business and Basis of Presentation [Line Items]
Number of stores	194
Edit stores
Description of Business and Basis of Presentation [Line Items]
Number of stores	11
UpWest
Description of Business and Basis of Presentation [Line Items]
Number of stores	12
Bonobos
Description of Business and Basis of Presentation [Line Items]
Number of stores	59

Revenue Recognition - Revenue b

Revenue Recognition - Revenue by Major Product Categories and Sales Channels (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Disaggregation of Revenue [Line Items]
Total net sales	$ 454,063	$ 434,145	$ 1,272,664	$ 1,349,849
Apparel
Disaggregation of Revenue [Line Items]
Total net sales	411,242	389,338	1,150,342	1,207,572
Accessories and other
Disaggregation of Revenue [Line Items]
Total net sales	26,981	31,888	80,818	103,060
Retail
Disaggregation of Revenue [Line Items]
Total net sales	337,180	302,652	926,862	943,822
Outlet
Disaggregation of Revenue [Line Items]
Total net sales	101,043	118,574	304,298	366,810
Other revenue
Disaggregation of Revenue [Line Items]
Total net sales	$ 15,840	$ 12,919	$ 41,504	$ 39,217

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	May 23, 2023	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022	Jul. 29, 2023	Jan. 28, 2023	Jul. 30, 2022	Jan. 29, 2022	Jan. 31, 2018
Disaggregation of Revenue [Line Items]
Redemption period for rewards earned				60 days
Sales returns reserve		$ 14,400		$ 14,400			$ 9,000
Gift card liability		39,395		39,395			35,543
Gift Card Liability
Disaggregation of Revenue [Line Items]
Gift card liability		29,424	$ 22,166	29,424	$ 22,166	$ 30,350	25,604	$ 22,753	$ 25,066
Gift card liabilities acquired	$ 7,500
Revenue recognized		2,400	2,900	11,300	10,400
Comenity Bank
Disaggregation of Revenue [Line Items]
Revenue recognized		719	719	2,158	2,158
Deferred revenue		3,358	$ 6,236	3,358	$ 6,236	$ 4,077	$ 5,516	$ 6,955	$ 8,394
Comenity Bank | Credit Card
Disaggregation of Revenue [Line Items]
Deferred revenue		$ 3,400		$ 3,400						$ 20,000

Revenue Recognition - Loyalty D

Revenue Recognition - Loyalty Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Contract With Customer, Liability [Roll Forward]
Beginning balance			$ 35,543
Ending balance	$ 39,395		39,395
Loyalty Program
Contract With Customer, Liability [Roll Forward]
Beginning balance	9,030	$ 8,754	9,939	$ 10,918
Reduction in revenue/(revenue recognized)	878	462	(31)	(1,702)
Ending balance	$ 9,908	$ 9,216	$ 9,908	$ 9,216

Revenue Recognition - Gift Card

Revenue Recognition - Gift Card Liability (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Contract With Customer, Liability [Roll Forward]
Beginning balance			$ 35,543
Ending balance	$ 39,395		39,395
Gift Card Liability
Contract With Customer, Liability [Roll Forward]
Beginning balance	30,350	$ 22,753	25,604	$ 25,066
Ending balance	29,424	22,166	29,424	22,166
Issuances and acquired
Contract With Customer, Liability [Roll Forward]
Increase (decrease) in gift card liability	6,497	5,575	25,205	18,188
Redemptions
Contract With Customer, Liability [Roll Forward]
Increase (decrease) in gift card liability	(6,943)	(5,601)	(19,479)	(18,923)
Gift card breakage
Contract With Customer, Liability [Roll Forward]
Increase (decrease) in gift card liability	$ (480)	$ (561)	$ (1,906)	$ (2,165)

Revenue Recognition - Refundabl

Revenue Recognition - Refundable Payment Liability (Details) - Comenity Bank - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Contract With Customer, Liability [Roll Forward]
Beginning balance refundable payment liability	$ 4,077	$ 6,955	$ 5,516	$ 8,394
Recognized in revenue	(719)	(719)	(2,158)	(2,158)
Ending balance refundable payment liability	$ 3,358	$ 6,236	$ 3,358	$ 6,236

Earnings Per Share- Basic and D

Earnings Per Share- Basic and Diluted Earnings per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Earnings Per Share [Abstract]
Weighted-average shares - basic (in shares)	3,746	3,414	3,725	3,394
Dilutive effect of stock options and restricted stock units (in shares)	0	0	0	0
Weighted-average shares - diluted (in shares)	3,746	3,414	3,725	3,394

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from computation of earnings per share (in shares)	0.2	0.2	0.2	0.3
Performance Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from computation of earnings per share (in shares)	0.2

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Assets Measured on Recurring Basis (Details) - Money market funds - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	$ 0	$ 47,792
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($)		3 Months Ended	9 Months Ended
	Jan. 25, 2023	Oct. 28, 2023	Oct. 28, 2023	Jan. 28, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds received from contributing intellectual property to joint venture			$ 260,000,000
Impairment charge related to equity method investments		$ 0	$ 0
EXP Topco LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds received from contributing intellectual property to joint venture	$ 235,000,000
Equity method investment, ownership percentage	40%	40%	40%	40%

Fair Value Measurements - Impai

Fair Value Measurements - Impairment Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Accounting Policies [Abstract]
Right of use asset impairment	$ 812	$ 0	$ 1,221	$ 0
Property and equipment asset impairment	304	0	891	0
Total asset impairment	$ 1,116	$ 0	$ 2,112	$ 0

Equity Method Investment - Sche

Equity Method Investment - Schedule of Equity Method Investment (Details) - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023	Jan. 25, 2023
Schedule of Equity Method Investments [Line Items]
Equity Method Investment	$ 166,210	$ 166,106
EXP Topco LLC
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	40%	40%	40%
Equity Method Investment	$ 166,210	$ 156,700	$ 156,700

Equity Method Investment - Narr

Equity Method Investment - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions				3 Months Ended			9 Months Ended
	May 23, 2023	Jan. 25, 2023	Dec. 08, 2022	Oct. 28, 2023	Jan. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Schedule of Equity Method Investments [Line Items]
Equity method investments, lag on reporting, period				1 month			1 month
Proceeds received from contributing intellectual property to joint venture							$ 260,000,000
Equity method investment				$ 166,210,000	$ 166,106,000		166,210,000
License agreement, term	10 years	10 years
License agreement, renewal term	10 years	10 years
License agreement, minimum notice period for nonrenewal	24 months	24 months
License agreement, annual guaranteed minimum royalty in first year	$ 6,500,000	$ 60,000,000
License agreement, annual guaranteed minimum royalty increase per year after first year and thru fifth year		$ 1,000,000
License agreement, annual guaranteed minimum royalty increase per year, period		5 years
License agreement, annual guaranteed minimum royalty at sixth year and thereafter		$ 65,000,000
License agreement, royalty percentage on net sales from retail of certain licensed goods thru fifth year	3.25%	3.25%
License agreement, royalty percentage on net sales from retail of certain licensed goods, thereafter fifth year	3.50%	3.50%
License agreement, royalty percentage on net sales from wholesale of certain licensed goods	8%	8%
Prepaid royalties, initially recorded		$ 60,000,000
Royalty income				$ 5,387,000		$ 0	$ 16,020,000	$ 0
WHP | Private Placement
Schedule of Equity Method Investments [Line Items]
Sale of stock, pro forma ownership percentage			7.40%
Gain on sale of stock			$ 17,800,000
WH Borrower, LLC | Private Placement
Schedule of Equity Method Investments [Line Items]
Shares sold in offering (in shares)			5.4
Purchase price (in USD per share)			$ 4.60
Purchase price			$ 25,000,000
EXP Topco LLC
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage		40%		40%	40%		40%
Proceeds received from contributing intellectual property to joint venture		$ 235,000,000
Ownership interest by third party		60%
Equity method investment		$ 156,700,000		$ 166,210,000	$ 156,700,000		$ 166,210,000
Equity method investment, transaction costs					9,400,000
EXP Topco LLC | Intellectual Property
Schedule of Equity Method Investments [Line Items]
Finite-lived intangible assets, net					0
Gain on contribution of intangible assets					$ 391,700,000
EXP Topco LLC | WHP
Schedule of Equity Method Investments [Line Items]
Payments to acquire interest in joint venture		$ 235,000,000

Equity Method Investment - Summ

Equity Method Investment - Summarized Income Statement Impact from Equity Method Investments (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 28, 2023	Oct. 29, 2022
Schedule of Equity Method Investments [Line Items]
Equity method investments, lag on reporting, period	1 month						1 month
Total net sales	$ 454,063			$ 434,145			$ 1,272,664	$ 1,349,849
GROSS PROFIT	109,517			120,617			273,679	405,818
Operating expenses	138,259			150,126			412,107	434,018
Interest income	6,170			4,668			12,987	11,962
LOSS BEFORE INCOME TAXES	(34,912)			(33,668)			(151,415)	(38,777)
Net income (loss)	(36,811)	$ (44,056)	$ (73,427)	$ (34,448)	$ 7,036	$ (11,914)	(154,294)	$ (39,326)
Income attributable to the equity method investment	5,387						16,020
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Schedule of Equity Method Investments [Line Items]
Total net sales	15,920						43,643
GROSS PROFIT	15,920						43,643
Operating expenses	7,163						19,553
Interest income	(50)						(64)
LOSS BEFORE INCOME TAXES	8,807						24,154
Net income (loss)	$ 8,455						$ 23,188

Equity Method Investment - Su_2

Equity Method Investment - Summarized Balance Sheet Impact from Equity Method Investments (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 28, 2023	Oct. 28, 2023	Jan. 28, 2023
Schedule of Equity Method Investments [Line Items]
Current assets	$ 598,879	$ 598,879	$ 534,404
TOTAL ASSETS	1,467,758	1,467,758	1,398,325
Current liabilities	613,068	613,068	541,590
Total Liabilities	1,319,803	1,319,803	1,090,756
Equity method investment	$ 166,210	$ 166,210	$ 166,106
Equity method investments, lag on reporting, period	1 month	1 month
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Schedule of Equity Method Investments [Line Items]
Current assets	$ 8,651	$ 8,651
Non-current assets	407,011	407,011
TOTAL ASSETS	415,662	415,662
Current liabilities	21,073	21,073
Non-current liabilities	0	0
Total Liabilities	$ 21,073	$ 21,073

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Millions			3 Months Ended	9 Months Ended
	May 23, 2023	Jan. 25, 2023	Oct. 28, 2023	Oct. 28, 2023
Business Acquisition [Line Items]
License agreement, term	10 years	10 years
License agreement, renewal term	10 years	10 years
License agreement, minimum notice period for nonrenewal	24 months	24 months
License agreement, annual guaranteed minimum royalty in first year	$ 6.5	$ 60
License agreement, annual guaranteed minimum royalty at tenth year and thereafter	$ 11.5
License agreement, royalty percentage on net sales from retail of certain licensed goods thru fifth year	3.25%	3.25%
License agreement, royalty percentage on net sales from retail of certain licensed goods, thereafter fifth year	3.50%	3.50%
License agreement, royalty percentage on net sales from wholesale of certain licensed goods	8%	8%
Bonobos
Business Acquisition [Line Items]
Consideration transferred	$ 28.3
Business purchase price	25
Certain customary adjustments related to net working capital	2
Prepaid rent	$ 1.3
Acquisition related costs				$ 5
Aggregate net sales			$ 52.1	93
Net income			$ 2.1	$ 4.4

Acquisitions - Recognized Ident

Acquisitions - Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		9 Months Ended
	May 23, 2023	Oct. 28, 2023	Oct. 29, 2022
Purchase Price
Cash paid		$ 28,300	$ 0
Bonobos
Purchase Price
Cash paid	$ 28,300
Allocation
Receivables, net	2,071
Inventory	51,293
Right of use asset, net	27,914
Property and equipment, net	2,858
Other assets acquired	5,827
Assets acquired	89,963
Short-term lease liability	(6,698)
Accounts payable	(9,479)
Deferred revenue	(9,077)
Long-term lease liability	(23,617)
Accrued expenses and other liabilities assumed	(12,792)
Liabilities assumed	(61,663)
Recognized identifiable assets acquired and liabilities assumed, net	$ 28,300

Acquisitions - Pro Forma Inform

Acquisitions - Pro Forma Information (Details) - Bonobos - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Business Acquisition [Line Items]
Net sales	$ 454,063	$ 487,109	$ 1,341,684	$ 1,490,613
Net loss	$ (36,811)	$ (34,476)	$ (160,559)	$ (46,419)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022	Jan. 28, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	(5.40%)	(2.30%)	(1.90%)	(1.40%)
Non-current income tax receivable	$ 45,079		$ 45,079		$ 52,278

Leases - Narrative (Details)

Leases - Narrative (Details)	9 Months Ended
	Oct. 28, 2023 renewal_option
Office Building
Lessee, Lease, Description [Line Items]
Number of renewal options	1
Lease renewal term	5 years
Minimum | Stores
Lessee, Lease, Description [Line Items]
Lease term	5 years
Minimum | Equipment and Other Assets
Lessee, Lease, Description [Line Items]
Lease term	3 years
Maximum | Stores
Lessee, Lease, Description [Line Items]
Lease term	10 years
Maximum | Equipment and Other Assets
Lessee, Lease, Description [Line Items]
Lease term	5 years

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$ 191,318	$ 189,587
Right of use assets obtained in exchange for operating lease liabilities	$ 156,087	$ 39,958

Debt - Outstanding Debt (Detail

Debt - Outstanding Debt (Details) - USD ($) $ in Thousands	Oct. 28, 2023	Sep. 05, 2023	Jan. 28, 2023
Debt Instrument [Line Items]
Total outstanding borrowings	$ 277,731		$ 122,000
Less: unamortized debt issuance costs	(3,059)		0
Total long-term debt, net	274,672		122,000
Less: current portion of long-term debt	4,159		0
Total long-term debt, net	270,513		122,000
Line of Credit
Debt Instrument [Line Items]
Outstanding letters of credit	20,082		19,636
Line of Credit | Revolving Credit Facility | Asset-Based Loan Credit Agreement
Debt Instrument [Line Items]
Total outstanding borrowings	212,731		122,000
Line of Credit | Secured Debt | Term Loan Agreement
Debt Instrument [Line Items]
Total outstanding borrowings	65,000	$ 65,000	$ 0
Less: unamortized debt issuance costs	$ (3,100)

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)			9 Months Ended
	Sep. 13, 2023	Sep. 05, 2023	Oct. 28, 2023	Oct. 29, 2022	Jan. 28, 2023
Debt Instrument [Line Items]
Proceeds from term loans			$ 65,000,000	$ 0
Total outstanding borrowings			277,731,000		$ 122,000,000
Unamortized deferred financing costs			3,059,000		0
Line of Credit
Debt Instrument [Line Items]
Outstanding letters of credit			20,082,000		19,636,000
Line of Credit | Asset-Based Loan Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity			290,000,000
Line of credit, borrowings outstanding			$ 212,700,000
Unused line fee payable			0.25%
Debt, covenant, minimum excess availability, amount			$ 25,000,000
Debt, covenant, minimum excess availability, percentage			10%
Debt instrument, covenant, EBITDA threshold, two consecutive quarters			$ 50,000,000
Debt instrument, remaining borrowing capacity, consecutive trading days			30 days
Debt instrument, covenant, minimum fixed charge coverage ratio			1
Debt default, principal, additional interest rate			2%
Debt default, base rate loans, additional interest rate			2%
Line of credit, remaining borrowing capacity			$ 21,700,000
Debt, fair value			201,500,000		115,000,000
Total outstanding borrowings			212,731,000		122,000,000
Line of Credit | Asset-Based Loan Credit Agreement | Letter of Credit
Debt Instrument [Line Items]
Outstanding letters of credit			20,100,000		19,600,000
Line of Credit | Asset-Based Loan Credit Agreement | Trade Letter Of Credit
Debt Instrument [Line Items]
Outstanding letters of credit			$ 0		0
Expiration term for trade letters of credit			21 days
Line of Credit | Term Loan Agreement | Secured Debt
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 65,000,000
Debt, covenant, minimum excess availability, amount		$ 25,000,000
Debt, covenant, minimum excess availability, percentage		10%
Debt, fair value			$ 40,200,000
Proceeds from term loans	$ 32,500,000	$ 32,500,000
Total outstanding borrowings		$ 65,000,000	$ 65,000,000		$ 0
Stated interest rate			15.40%
Debt default, additional interest rate		3%
Unamortized deferred financing costs			$ 3,100,000
Line of Credit | Term Loan Agreement | Secured Debt | Debt Instrument, Tranche One
Debt Instrument [Line Items]
Periodic principal payment		$ 700,000
Line of Credit | Term Loan Agreement | Secured Debt | Debt Instrument, Tranche Two
Debt Instrument [Line Items]
Periodic principal payment		$ 1,200,000
Line of Credit | Secured Overnight Financing Rate (SOFR) | Asset-Based Loan Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Effective interest rate			8%
Line of Credit | Secured Overnight Financing Rate (SOFR) | Asset-Based Loan Credit Agreement | Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate			1.75%
Line of Credit | Secured Overnight Financing Rate (SOFR) | Asset-Based Loan Credit Agreement | Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate			2.25%
Line of Credit | Secured Overnight Financing Rate (SOFR) | Term Loan Agreement | Secured Debt
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate		10%

Long-Term Incentive Compensat_3

Long-Term Incentive Compensation - Shared-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	$ (1,141)	$ 2,604	$ (4,951)	$ 7,617
Long-term incentive compensation	(356)	6,053	1,335	17,211
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	23	1,015	869	3,292
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	0	88	161	263
Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	(1,164)	1,501	(5,981)	4,062
Cash-settled awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Long-term incentive compensation	$ 785	$ 3,449	$ 6,286	$ 9,594

Long-Term Incentive Compensat_4

Long-Term Incentive Compensation - Narrative (Details) - USD ($) shares in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022	Jan. 28, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax benefit from share-based compensation expense	$ 100,000	$ 100,000	$ 4,200,000	$ 3,000,000
Tax benefit from share-based compensation expense, valuation allowance	100,000	$ 100,000	4,200,000	3,000,000
Unrecognized compensation expense related to stock options	0		0
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of options vested			3,500,000	$ 5,200,000
Unrecognized compensation costs, excluding stock options	100,000		$ 100,000
Unrecognized compensation costs, period for recognition			1 year 1 month 6 days
Granted (in shares)			1
Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period					3 years
Unrecognized compensation costs, excluding stock options	$ 300,000		$ 300,000
Unrecognized compensation costs, period for recognition			3 years 3 months 18 days
Award performance period					3 years
Performance-based restricted stock units | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	150
Time-Based Cash-Settled Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			3 years
Unrecognized compensation costs, excluding stock options	$ 9,800,000		$ 9,800,000
Unrecognized compensation costs, period for recognition			1 year 4 months 24 days
Performance-Based Cash-Settled Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, excluding stock options	$ 1,300,000		$ 1,300,000
Unrecognized compensation costs, period for recognition			2 years 6 months
Award performance period			3 years
Minimum | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			1 year
Minimum | Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of performance award which can be earned					0%
Minimum | Performance-Based Cash-Settled Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of performance award which can be earned			0%
Maximum | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			3 years
Maximum | Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of performance award which can be earned					200%
Maximum | Performance-based restricted stock units | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of performance award which can be earned	200%
Maximum | Performance-Based Cash-Settled Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of performance award which can be earned			200%

Long-Term Incentive Compensat_5

Long-Term Incentive Compensation - Restricted Stock Units, Including Awards with Performance Conditions (Details) - Restricted stock units shares in Thousands	9 Months Ended
	Oct. 28, 2023 $ / shares shares
Number of Shares
Unvested at beginning of period (in shares) | shares	87
Granted (in shares) | shares	1
Vested (in shares) | shares	(80)
Forfeited (in shares) | shares	(6)
Unvested at end of period (in shares) | shares	2
Grant Date Weighted Average Fair Value Per Share
Unvested at beginning of period (in USD per share) | $ / shares	$ 45.38
Granted (in USD per share) | $ / shares	22.80
Vested (in USD per share) | $ / shares	44.01
Forfeited (in USD per share) | $ / shares	59.98
Unvested at end of period (in USD per share) | $ / shares	$ 57.91

Long-Term Incentive Compensat_6

Long-Term Incentive Compensation - Stock Options Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Oct. 28, 2023 USD ($) $ / shares shares
Number of Shares
Outstanding at beginning of period (in shares) | shares	143
Granted (in shares) | shares	0
Exercised (in shares) | shares	0
Forfeited or expired (in shares) | shares	(6)
Outstanding at end of period (in shares) | shares	137
Expected to vest at end of period (in shares) | shares	0
Exercisable at end of period (in shares) | shares	137
Grant Date Weighted Average Exercise Price Per Share
Outstanding at beginning of period (in USD per share) | $ / shares	$ 96.86
Granted (in USD per share) | $ / shares	0
Exercised (in USD per share) | $ / shares	0
Forfeited or expired (in USD per share) | $ / shares	335.40
Outstanding at end of period (in USD per share) | $ / shares	87.47
Expected to vest at end of period (in USD per share) | $ / shares	0
Exercisable at end of period (in USD per share) | $ / shares	$ 87.47
Weighted-Average Remaining Contractual Life (in years)
Outstanding at end of period	5 years 2 months 12 days
Expected to vest at end of period	0 years
Exercisable at end of period	5 years 2 months 12 days
Aggregate Intrinsic Value
Outstanding at end of period | $	$ 0
Expected to vest at end of period | $	0
Exercisable at end of period | $	$ 0

Stockholders' Equity (Details)

Stockholders' Equity (Details) $ / shares in Units, $ in Millions		3 Months Ended		9 Months Ended
	Aug. 30, 2023 $ / shares shares	Oct. 28, 2023 USD ($) $ / shares shares	Oct. 29, 2022 shares	Oct. 28, 2023 USD ($) $ / shares shares	Oct. 29, 2022 shares	Aug. 29, 2023 shares	Aug. 14, 2023 $ / shares	Jan. 28, 2023 $ / shares shares	Nov. 28, 2017 USD ($)
Class of Stock [Line Items]
Stock repurchase program, authorized amount | $									$ 150
Repurchase of common stock (in shares) | shares		0	0	0	0
Stock repurchase program, remaining authorized amount | $		$ 34.2		$ 34.2
Common stock, authorized (in shares) | shares	25,000,000	25,000,000		25,000,000		500,000,000		25,000,000
Common stock, par value (in USD per share) | $ / shares	$ 0.01	$ 0.01		$ 0.01			$ 0.01	$ 0.01
Common Stock, $.01 par value
Class of Stock [Line Items]
Reverse stock split, conversion ratio	0.05